US20140137744A1 - Oxygen concentrator systems and methods - Google Patents
Oxygen concentrator systems and methods Download PDFInfo
- Publication number
- US20140137744A1 US20140137744A1 US14/053,029 US201314053029A US2014137744A1 US 20140137744 A1 US20140137744 A1 US 20140137744A1 US 201314053029 A US201314053029 A US 201314053029A US 2014137744 A1 US2014137744 A1 US 2014137744A1
- Authority
- US
- United States
- Prior art keywords
- canister
- oxygen
- oxygen concentrator
- gas
- canisters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/1005—Preparation of respiratory gases or vapours with O2 features or with parameter measurement
- A61M16/101—Preparation of respiratory gases or vapours with O2 features or with parameter measurement using an oxygen concentrator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/06—Respiratory or anaesthetic masks
- A61M16/0666—Nasal cannulas or tubing
- A61M16/0672—Nasal cannula assemblies for oxygen therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
- B01D53/02—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols by adsorption, e.g. preparative gas chromatography
- B01D53/04—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols by adsorption, e.g. preparative gas chromatography with stationary adsorbents
- B01D53/0407—Constructional details of adsorbing systems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
- B01D53/02—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols by adsorption, e.g. preparative gas chromatography
- B01D53/04—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols by adsorption, e.g. preparative gas chromatography with stationary adsorbents
- B01D53/047—Pressure swing adsorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/105—Filters
- A61M16/1055—Filters bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/105—Filters
- A61M16/106—Filters in a path
- A61M16/107—Filters in a path in the inspiratory path
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/0015—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
- A61M2016/0018—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
- A61M2016/0021—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with a proportional output signal, e.g. from a thermistor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/0027—Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
- A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/1005—Preparation of respiratory gases or vapours with O2 features or with parameter measurement
- A61M2016/102—Measuring a parameter of the content of the delivered gas
- A61M2016/1025—Measuring a parameter of the content of the delivered gas the O2 concentration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/40—Respiratory characteristics
- A61M2230/42—Rate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2253/00—Adsorbents used in seperation treatment of gases and vapours
- B01D2253/10—Inorganic adsorbents
- B01D2253/106—Silica or silicates
- B01D2253/108—Zeolites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2256/00—Main component in the product gas stream after treatment
- B01D2256/12—Oxygen
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2257/00—Components to be removed
- B01D2257/10—Single element gases other than halogens
- B01D2257/102—Nitrogen
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2257/00—Components to be removed
- B01D2257/80—Water
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2257/00—Components to be removed
- B01D2257/91—Bacteria; Microorganisms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2258/00—Sources of waste gases
- B01D2258/06—Polluted air
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2259/00—Type of treatment
- B01D2259/40—Further details for adsorption processes and devices
- B01D2259/40007—Controlling pressure or temperature swing adsorption
- B01D2259/40009—Controlling pressure or temperature swing adsorption using sensors or gas analysers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2259/00—Type of treatment
- B01D2259/40—Further details for adsorption processes and devices
- B01D2259/40083—Regeneration of adsorbents in processes other than pressure or temperature swing adsorption
- B01D2259/40088—Regeneration of adsorbents in processes other than pressure or temperature swing adsorption by heating
- B01D2259/40098—Regeneration of adsorbents in processes other than pressure or temperature swing adsorption by heating with other heating means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2259/00—Type of treatment
- B01D2259/40—Further details for adsorption processes and devices
- B01D2259/402—Further details for adsorption processes and devices using two beds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2259/00—Type of treatment
- B01D2259/45—Gas separation or purification devices adapted for specific applications
- B01D2259/4533—Gas separation or purification devices adapted for specific applications for medical purposes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2259/00—Type of treatment
- B01D2259/45—Gas separation or purification devices adapted for specific applications
- B01D2259/4541—Gas separation or purification devices adapted for specific applications for portable use, e.g. gas masks
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2259/00—Type of treatment
- B01D2259/80—Employing electric, magnetic, electromagnetic or wave energy, or particle radiation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
- B01D53/02—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols by adsorption, e.g. preparative gas chromatography
- B01D53/04—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols by adsorption, e.g. preparative gas chromatography with stationary adsorbents
- B01D53/0407—Constructional details of adsorbing systems
- B01D53/0438—Cooling or heating systems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
- B01D53/02—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols by adsorption, e.g. preparative gas chromatography
- B01D53/04—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols by adsorption, e.g. preparative gas chromatography with stationary adsorbents
- B01D53/0407—Constructional details of adsorbing systems
- B01D53/0446—Means for feeding or distributing gases
Abstract
Described herein are various embodiments of an oxygen concentrator system. In some embodiments, oxygen concentrator system includes one or more components that improve energy usage during operation of the oxygen concentrator system.
Description
- This application claims priority to U.S. Provisional Application Ser. No. 61/713,254 entitled “Oxygen Concentrator Systems and Methods for Oral Delivery of Oxygen Enriched Air” filed Oct. 12, 2012, which is incorporated herein by reference in its entirety; and U.S. Provisional Application Ser. No. 61/804,369 entitled “Oxygen Concentrator Systems and Methods for Oral Delivery of Oxygen Enriched Gas” filed Mar. 22, 2013, which is incorporated herein by reference in its entirety.
- 1. Field of the Invention
- The present invention relates generally to health equipment and, more specifically, to oxygen concentrators.
- 2. Description of the Related Art
- There are many patients that require supplemental oxygen as part of Long Term Oxygen Therapy (LTOT). Currently, the vast majority of patients that are receiving LTOT are diagnosed under the general category of Chronic Obstructive Pulmonary Disease, COPD. This general diagnosis includes such common diseases as Chronic Asthma, Emphysema, Congestive Heart Failure and several other cardio-pulmonary conditions. Other people (e.g., obese individuals) may also require supplemental oxygen, for example, to maintain elevated activity levels.
- Doctors may prescribe oxygen concentrators or portable tanks of medical oxygen for these patients. Usually a specific oxygen flow rate is prescribed (e.g., 1 liter per minute (LPM), 2 LPM, 3 LPM, etc.). Experts in this field have also recognized that exercise for these patients provide long term benefits that slow the progression of the disease, improve quality of life and extend patient longevity. Most stationary forms of exercise like tread mills and stationary bicycles, however, are too strenuous for these patients. As a result, the need for mobility has long been recognized. Until recently, this mobility has been facilitated by the use of small compressed oxygen tanks. The disadvantage of these tanks is that they have a finite amount of oxygen and they are heavy, weighing about 50 pounds, when mounted on a cart with dolly wheels.
- Oxygen concentrators have been in use for about 50 years to supply patients suffering from respiratory insufficiency with supplemental oxygen. Traditional oxygen concentrators used to provide these flow rates have been bulky and heavy making ordinary ambulatory activities with them difficult and impractical. Recently, companies that manufacture large stationary home oxygen concentrators began developing portable oxygen concentrators, POCs. The advantage of POCs concentrators was that they can produce a theoretically endless supply of oxygen. In order to make these devices small for mobility, the various systems necessary for the production of oxygen enriched gas are condensed.
- Systems and methods of providing an oxygen enriched gas to a user of an oxygen concentrator are described herein.
- In some embodiments, a method of providing an oxygen enriched gas to a user of an oxygen concentrator includes assessing a preselected prescription for the oxygen concentrator. Based on the preselected prescription, the compressor is operated at a percentage of the normal maximum compressor speed, wherein the percentage is assessed based on the preselected prescription. When the prescription is changed, the compressor speed is changed to a different percentage of the normal maximum compressor speed based on changes in the prescription.
- The method may also include assessing the breathing rate of the user during use of the oxygen concentrator and operating the compressor at a percentage of the normal maximum compressor speed, wherein the percentage is assessed based on the preselected prescription and the assessed breathing rate. If the users breathing rate changes, the controller may adjust the compressor speed to a different percentage of the normal maximum compressor speed, based on changes in the prescription and the assessed breathing rate.
- The controller may be configured to run the compressor at a speed less than the normal maximum compressor speed when the prescription is set at or below a predetermined rate. The controller may also be configured to run the compressor at a speed greater than the normal maximum compressor speed when a breathing rate of the user exceeds a predetermined breathing rate and when the prescription is set at or above a predetermined rate.
- In an embodiment, the compression system comprises a first compressor and a second compressor. While two compressors are described, it should be understood that three of more compressors may be used in a compression system. The controller is configured to automatically run one of the first compressor or the second compressor when the prescription is set at or below a predetermined rate, wherein the selection of the first compressor or the second compressor is arbitrarily made by the controller. The controller is further configured to automatically increase the speed of the first compressor or second compressor if the breathing rate of the user increases or the prescription increases. If the first compressor or second compressor reaches a predetermined percentage of the normal maximum compressor speed, the compressor that is not in operation may be turned on. When the predetermined percentage of the normal maximum compressor speed is less than 100%, and when the compressor that was not in operation is turned on, both the first compressor and the second compressor are run at a speed of less than 100% of the normal maximum compressor speed. In some embodiments, the first compressor and the second compressor are operated at the same percentage of the normal compressor speed.
- In some embodiments, an oxygen concentrator includes at least one canister; gas separation adsorbent disposed in at least one canister, at least two electrodes coupled to at least one canister, and a power supply coupled to at least one of the electrodes. The gas separation adsorbent separates at least some nitrogen from air in the canister to produce oxygen enriched gas. The power supply is configured to electrically excite at least one of the electrodes such that current flows between the electrodes and ionizes air between the two electrodes. The ionized air assists in removal of at least one compound from the gas separation adsorbent. At least one compound is water and/or bacteria.
- In some embodiments, a method of treating gas separation adsorbent of an oxygen concentrator includes providing electrical current to a first electrode such that electrical current flows from the first electrode to a second electrode; the electrical current flowing through at least a portion of the gas adsorbent and ionizing air in the gas separation adsorbent; and removing one or more compounds from the ionized gas separation adsorbent.
- In some embodiments, a method of treating gas separation adsorbent in an oxygen concentrator includes providing air to the gas separation adsorbent, providing electrical current to a first electrode such that electrical current flows from the first electrode to a second electrode; the electrical current flowing through at least a portion of the gas adsorbent and ionizing at least a portion of the provided air, and removing one or more compounds from the gas separation adsorbent.
- A method of operating an oxygen concentrator system includes providing at least two electrodes to at least one canister of a first oxygen concentrator of the oxygen concentrator system, the gas canister comprising gas separation adsorbent. Electrical current is to a first electrode of the two electrodes such that electrical current flows from the first electrode to a second electrode of the two electrodes. The electrical current flows through at least a portion of a gas adsorbent for a period of time. The canister after the period of time has elapsed is provided to a second oxygen concentrator of the oxygen concentrator system.
- A method of providing oxygen enriched gas to a user of an oxygen concentrator system, includes automatically assessing a state of the gas separation adsorbent and operating the power supply at a voltage sufficient to electrically excite at least one of the electrodes such that current flows between the electrodes and ionizes the gas separation adsorbent.
- A method of operating an oxygen concentrator system includes turning an oxygen concentrator apparatus to an off position, assessing a pressure of one or more canisters of the turned-off oxygen concentrator, and pressurizing at least one canister when the assessed pressure is below a desired pressure.
- A method of providing oxygen enriched gas to a user of an oxygen concentrator includes automatically assessing a state of the oxygen concentrator, automatically assessing a pressure of at least one of the canisters for the oxygen concentrator, wherein the pressure is assessed during an off state, and operating the compressor at a compressor speed sufficient to pressurize at least one of the canisters to a desired pressure based on the assessed pressure of the oxygen concentrator.
- In an embodiment, an oxygen concentrator includes: at least two canisters; gas separation adsorbent disposed in at least two canisters, wherein the gas separation adsorbent separates at least some nitrogen from air in the canister to produce oxygen enriched gas; a compression system comprising at least one compressor coupled to at least one canister; an accumulator for storing oxygen enriched gas produced from the at least two canisters; and one or more oxygen sensors coupled to the accumulator. During use the oxygen concentrator may be operated by: automatically assessing a purity of the oxygen enriched gas stored in the accumulator, based on data obtained from the one or more oxygen sensors; operating the compressor at speed that is based on the purity of oxygen enriched gas in the accumulator; and adjusting the compressor speed based on changes in the purity of oxygen enriched gas in the accumulator.
- Advantages of the present invention will become apparent to those skilled in the art with the benefit of the following detailed description of embodiments and upon reference to the accompanying drawings in which:
-
FIG. 1 depicts a schematic diagram of an embodiment of the components of an oxygen concentrator. -
FIG. 2 depicts a schematic diagram of an embodiment of the outlet components of an oxygen concentrator. -
FIG. 3 depicts a schematic diagram of an embodiment of an outlet conduit for an oxygen concentrator; -
FIG. 4 depicts a perspective view of an embodiment of a dissembled canister system; -
FIG. 5 depicts a perspective view of an embodiment of an end of a canister system. -
FIG. 6 depicts the assembled end of an embodiment of the canister system end depicted inFIG. 5 . -
FIG. 7 depicts a perspective view of an embodiment of an opposing end of the canister system depicted inFIGS. 4 and 5 . -
FIG. 8 depicts a perspective view of an embodiment of the assembled opposing end of the canister system end depicted inFIG. 7 . -
FIG. 9 depicts various profiles of embodiments for providing oxygen enriched gas from an oxygen concentrator. -
FIG. 10 depicts a perspective view of an embodiment of a canister having a tapered end. -
FIG. 11 a depicts a perspective view of an embodiment of a canister with baffles. -
FIG. 11 b depicts a perspective view of an embodiment of a tapered canister with baffles. -
FIG. 11 c depicts a top view of an embodiment of a canister with baffles. -
FIG. 12 depicts a perspective view of an embodiment of a canister that includes at least two electrodes in a canister. -
FIG. 13 depicts a top view of an embodiment of the canister ofFIG. 12 containing gas separation adsorbent. -
FIG. 14 depicts a perspective view of an embodiment of a canister that includes at least two electrodes. - While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof are shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that the drawings and detailed description thereto are not intended to limit the invention to the particular form disclosed, but on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the present invention as defined by the appended claims.
- It is to be understood the present invention is not limited to particular devices or methods, which may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting. Headings are for organizational purposes only and are not meant to be used to limit or interpret the description or claims. As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include singular and plural referents unless the content clearly dictates otherwise. Furthermore, the word “may” is used throughout this application in a permissive sense (i.e., having the potential to, being able to), not in a mandatory sense (i.e., must). The term “include,” and derivations thereof, mean “including, but not limited to.”
- The term “coupled” as used herein means either a direct connection or an indirect connection (e.g., one or more intervening connections) between one or more objects or components. The phrase “connected” means a direct connection between objects or components such that the objects or components are connected directly to each other. As used herein the phrase “obtaining” a device means that the device is either purchased or constructed.
- Oxygen concentrators take advantage of pressure swing adsorption (PSA). Pressure swing adsorption involves using a compressor to increase gas pressure inside a canister that contains particles of a gas separation adsorbent. As the pressure increases, certain molecules in the gas may become adsorbed onto the gas separation adsorbent. Removal of a portion of the gas in the canister under the pressurized conditions allows separation of the non-adsorbed molecules from the adsorbed molecules. The gas separation adsorbent may be regenerated by reducing the pressure, which reverses the adsorption of molecules from the adsorbent. Further details regarding oxygen concentrators may be found, for example, in U.S. Published Patent Application No. 2009-0065007, published Mar. 12, 2009, and entitled “Oxygen Concentrator Apparatus and Method”, which is incorporated herein by reference.
- Ambient air usually includes approximately 78% nitrogen and 21% oxygen with the balance comprised of argon, carbon dioxide, water vapor and other trace elements. If a gas mixture such as air, for example, is passed under pressure through a vessel containing a gas separation adsorbent bed that attracts nitrogen more strongly than it does oxygen, part or all of the nitrogen will stay in the bed, and the gas coming out of the vessel will be enriched in oxygen. When the bed reaches the end of its capacity to adsorb nitrogen, it can be regenerated by reducing the pressure, thereby releasing the adsorbed nitrogen. It is then ready for another cycle of producing oxygen enriched air. By alternating canisters in a two-canister system, one canister can be collecting oxygen while the other canister is being purged (resulting in a continuous separation of the oxygen from the nitrogen). In this manner, oxygen can be accumulated out of the air for a variety of uses include providing supplemental oxygen to patients.
-
FIG. 1 illustrates a schematic diagram of anoxygen concentrator 100, according to an embodiment.Oxygen concentrator 100 may concentrate oxygen out of an air stream to provide oxygen enriched gas to a user. As used herein, “oxygen enriched gas” is composed of at least about 50% oxygen, at least about 60% oxygen, at least about 70% oxygen, at least about 80% oxygen, at least about 90% oxygen, at least about 95% oxygen, at least about 98% oxygen, or at least about 99% oxygen. -
Oxygen concentrator 100 may be a portable oxygen concentrator. For example,oxygen concentrator 100 may have a weight and size that allows the oxygen concentrator to be carried by hand and/or in a carrying case. In one embodiment,oxygen concentrator 100 has a weight of less than about 20 lbs., less than about 15 lbs., less than about 10 lbs., or less than about 5 lbs. In an embodiment,oxygen concentrator 100 has a volume of less than about 1000 cubic inches, less than about 750 cubic inches; less than about 500 cubic inches, less than about 250 cubic inches, or less than about 200 cubic inches. - Oxygen may be collected from ambient air by pressurizing ambient air in
canisters - As shown in
FIG. 1 , air may enter the oxygen concentrator throughair inlet 106. Air may be drawn intoair inlet 106 bycompression system 200.Compression system 200 may draw in air from the surroundings of the oxygen concentrator and compress the air, forcing the compressed air into one or bothcanisters inlet muffler 108 may be coupled toair inlet 106 to reduce sound produced by air being pulled into the oxygen generator bycompression system 200. In an embodiment,inlet muffler 108 may be a moisture and sound absorbing muffler. For example, a water absorbent material (such as a polymer water absorbent material or a zeolite material) may be used to both absorb water from the incoming air and to reduce the sound of the air passing into theair inlet 106. -
Compression system 200 may include one or more compressors capable of compressing air. In some embodiments, compression system may include one, two, three, four, or more compressors.Compression system 200 as depicted that includescompressor 210 and motor 220. Motor 220 is coupled tocompressor 210 and provides an operating force to the compressor to operate the compression mechanism. Pressurized air, produced bycompression system 200, may be forced into one or both of thecanisters - In some embodiments, motor 220 is coupled to a pressurizing device (e.g. piston pump or a diaphragm pump). The pressuring device may be a piston pump that has multiple pistons. During operation, the pistons may be selectively turned on or off. In some embodiments, motor 220 may be coupled to multiple pumps. Each pump may be selectively turned on or off. For example,
controller 400 may determine which pumps or pistons should be operated based on predetermined operating conditions. - Coupled to each
canister 302/304 areinlet valves 122/124 andoutlet valves 132/134. As shown inFIG. 1 ,inlet valve 122 is coupled tocanister 302 andinlet valve 124 is coupled tocanister 304.Outlet valve 132 is coupled tocanister 302 andoutlet valve 134 is coupled tocanister 304.Inlet valves 122/124 are used to control the passage of air fromcompression system 200 to the respective canisters.Outlet valves 132/134 are used to release gas from the respective canisters during a venting process. In some embodiments,inlet valves 122/124 andoutlet valves 132/134 may be silicon plunger solenoid valves. Other types of valves, however, may be used. Plunger valves offer advantages over other kinds of valves by being quiet and having low slippage. - In some embodiments, a two-step valve actuation voltage may be used to control
inlet valves 122/124 andoutlet valves 132/134. For example, a high voltage (e.g., 24 V) may be applied to an inlet valve to open the inlet valve. The voltage may then be reduced (e.g., to 7 V) to keep the inlet valve open. Using less voltage to keep a valve open may use less power (Power=Voltage*Current). This reduction in voltage minimizes heat buildup and power consumption to extend run time from the battery. When the power is cut off to the valve, it closes by spring action. In some embodiments, the voltage may be applied as a function of time that is not necessarily a stepped response (e.g., a curved downward voltage between an initial 24 V and a final 7 V). - In some embodiments, air may be pulled into the oxygen concentrator through
compressors 305, 310. In some embodiments, air may flow fromcompressors 305, 310 tocanisters valves compressors 305, 310 lowing through the otherrespective valve respective canister valve 124 is closed, the air from bothcompressors 305, 310 may flow throughvalve 122. Ifvalve 122 is closed, the air from bothcompressors 305, 310 may flow throughvalve 124. In some embodiments,valve 122 andvalve 124 may alternate to alternately direct the air from thecompressors 305, 310 intorespective canisters - In an embodiment, pressurized air is sent into one of
canisters inlet valve 122 is opened whileinlet valve 124 is closed. Pressurized air fromcompression system 200 is forced intocanister 302, while being inhibited from enteringcanister 304 byinlet valve 124. In an embodiment, acontroller 400 is electrically coupled tovalves Controller 400 includes one ormore processors 410 operable to execute program instructions stored inmemory 420. The program instructions are operable to perform various predefined methods that are used to operate the oxygen concentrator.Controller 400 may include program instructions for operatinginlet valves inlet valves canister 302,outlet valve 132 is closed andoutlet valve 134 is opened. Similar to the inlet valves,outlet valves controller 400. - Check
valves canisters valves valves check valves - The term “check valve”, as used herein, refers to a valve that allows flow of a fluid (gas or liquid) in one direction and inhibits back flow of the fluid. Examples of check valves that are suitable for use include, but are not limited to: a ball check valve; a diaphragm check valve; a butterfly check valve; a swing check valve; a duckbill valve; and a lift check valve. Under pressure, nitrogen molecules in the pressurized ambient air are adsorbed by the gas separation adsorbent in the pressurized canister. As the pressure increases, more nitrogen is adsorbed until the gas in the canister is enriched in oxygen. The nonadsorbed gas molecules (mainly oxygen) flow out of the pressurized canister when the pressure reaches a point sufficient to overcome the resistance of the check valve coupled to the canister. In one embodiment, the pressure drop of the check valve in the forward direction is less than 1 psi. The break pressure in the reverse direction is greater than 100 psi. It should be understood, however, that modification of one or more components would alter the operating parameters of these valves. If the forward flow pressure is increased, there is, generally, a reduction in oxygen enriched gas production. If the break pressure for reverse flow is reduced or set too low, there is, generally, a reduction in oxygen enriched gas pressure.
- In an exemplary embodiment,
canister 302 is pressurized by compressed air produced incompression system 200 and passed intocanister 302. During pressurization ofcanister 302inlet valve 122 is open,outlet valve 132 is closed,inlet valve 124 is closed andoutlet valve 134 is open.Outlet valve 134 is opened whenoutlet valve 132 is closed to allow substantially simultaneous venting ofcanister 304 whilecanister 302 is pressurized.Canister 302 is pressurized until the pressure in canister is sufficient to opencheck valve 142. Oxygen enriched gas produced incanister 302 exits through check valve and, in one embodiment, is collected inaccumulator 106. - After some time the gas separation adsorbent will become saturated with nitrogen and will be unable to separate significant amounts of nitrogen from incoming air. This point is usually reached after a predetermined time of oxygen enriched gas production. In the embodiment described above, when the gas separation adsorbent in
canister 302 reaches this saturation point, the inflow of compressed air is stopped andcanister 302 is vented to remove nitrogen. During venting,inlet valve 122 is closed, andoutlet valve 132 is opened. Whilecanister 302 is being vented,canister 304 is pressurized to produce oxygen enriched gas in the same manner described above. Pressurization ofcanister 304 is achieved by closingoutlet valve 134 and openinginlet valve 124. The oxygen enriched gas exitscanister 304 throughcheck valve 144. - During venting of
canister 302,outlet valve 132 is opened allowing pressurized gas (mainly nitrogen) to exit the canister throughconcentrator outlet 130. In an embodiment, the vented gases may be directed throughmuffler 133 to reduce the noise produced by releasing the pressurized gas from the canister. As gas is released fromcanister 302, pressure in the canister drops. The drop in pressure may allow the nitrogen to become desorbed from the gas separation adsorbent. The released nitrogen exits the canister throughoutlet 130, resetting the canister to a state that allows renewed separation of oxygen from an air stream.Muffler 133 may include open cell foam (or another material) to muffle the sound of the gas leaving the oxygen concentrator. In some embodiments, the combined muffling components/techniques for the input of air and the output of gas may provide for oxygen concentrator operation at a sound level below 50 decibels. - During venting of the canisters, it is advantageous that at least a majority of the nitrogen is removed. In an embodiment, at least about 50%, at least about 60%, at least about 70%, at least about 80%, at least about 90%, at least about 95%, at least about 98%, or substantially all of the nitrogen in a canister is removed before the canister is re-used to separate oxygen from air. In some embodiments, a canister may be further purged of nitrogen using an oxygen enriched stream that is introduced into the canister from the other canister.
- In an exemplary embodiment, a portion of the oxygen enriched gas may be transferred from
canister 302 tocanister 304 whencanister 304 is being vented of nitrogen. Transfer of oxygen enriched gas fromcanister 302 to 304, during venting ofcanister 304, helps to further purge nitrogen (and other gases) from the canister. In an embodiment, oxygen enriched gas may travel throughflow restrictors Flow restrictors - Flow of oxygen enriched gas is also controlled by use of
valve 152 andvalve 154.Valves canister 302 is being vented and it is desirable to purgecanister 302 by passing a portion of the oxygen enriched gas being produced incanister 304 intocanister 302. A portion of oxygen enriched gas, upon pressurization ofcanister 304, will pass throughflow restrictor 151 intocanister 302 during venting ofcanister 302. Additional oxygen enriched air is passed intocanister 302, fromcanister 304, throughvalve 154 and flowrestrictor 155.Valve 152 may remain closed during the transfer process, or may be opened if additional oxygen enriched gas is needed. The selection ofappropriate flow restrictors valve 154 allows a controlled amount of oxygen enriched gas to be sent fromcanister 304 to 302. In an embodiment, the controlled amount of oxygen enriched gas is an amount sufficient to purgecanister 302 and minimize the loss of oxygen enriched gas through ventingvalve 132 ofcanister 302. While this embodiment describes venting ofcanister 302, it should be understood that the same process can be used to ventcanister 304 usingflow restrictor 151,valve 152 and flowrestrictor 153. - The pair of equalization/
vent valves 152/154 work withflow restrictors flow valves 152/154 may be operated as bi-directional valves, the flow rate through such valves varies depending on the direction of fluid flowing through the valve. For example, oxygen enriched gas flowing fromcanister 304 towardcanister 302 has a flow rate faster throughvalve 152 than the flow rate of oxygen enriched gas flowing fromcanister 302 towardcanister 304 throughvalve 152. If a single valve was to be used, eventually either too much or too little oxygen enriched gas would be sent between the canisters and the canisters would, over time, begin to produce different amounts of oxygen enriched gas. Use of opposing valves and flow restrictors on parallel air pathways may equalize the flow pattern of the oxygen between the two canisters. Equalizing the flow may allow for a steady amount of oxygen available to the user over multiple cycles and also may allow a predictable volume of oxygen to purge the other of the canisters. In some embodiments, the air pathway may not have restrictors but may instead have a valve with a built in resistance or the air pathway itself may have a narrow radius to provide resistance. - At times, oxygen concentrator may be shut down for a period of time. When an oxygen concentrator is shut down, the temperature inside the canisters may drop as a result of the loss of adiabatic heat from the compression system. As the temperature drops, the volume occupied by the gases inside the canisters will drop. Cooling of the canisters may lead to a negative pressure in the canisters. Valves (e.g.,
valves - In an embodiment, outside air may be inhibited from entering canisters after the oxygen concentrator is shut down by pressurizing both canisters prior to shut down. By storing the canisters under a positive pressure, the valves may be forced into a hermetically closed position by the internal pressure of the air in the canisters. In an embodiment, the pressure in the canisters, at shutdown, should be at least greater than ambient pressure. As used herein the term “ambient pressure” refers to the pressure of the surroundings that the oxygen generator is located (e.g. the pressure inside a room, outside, in a plane, etc.). In an embodiment, the pressure in the canisters, at shutdown, is at least greater than standard atmospheric pressure (i.e., greater than 760 mmHg (Torr), 1 atm, 101,325 Pa). In an embodiment, the pressure in the canisters, at shutdown, is at least about 1.1 times greater than ambient pressure; is at least about 1.5 times greater than ambient pressure; or is at least about 2 times greater than ambient pressure.
- In an embodiment, pressurization of the canisters may be achieved by directing pressurized air into each canister from the compression system and closing all valves to trap the pressurized air in the canisters. In an exemplary embodiment, when a shutdown sequence is initiated,
inlet valves outlet valves inlet valves canisters compression system 200. Wheninlet valves canisters compression system 200 may be operated for a time sufficient to increase the pressure inside both canisters to a level at least greater than ambient pressure. Regardless of the method of pressurization of the canisters, once the canisters are pressurized,inlet valves - An outlet system, coupled to one or more of the canisters, includes one or more conduits for providing oxygen enriched gas to a user. In an embodiment, oxygen enriched gas produced in either of
canisters accumulator 106 throughcheck valves FIG. 1 . The oxygen enriched gas leaving the canisters may be collected inoxygen accumulator 106 prior to being provided to a user. In some embodiments, a tube may be coupled toaccumulator 106 to provide the oxygen enriched gas to the user. Oxygen enriched gas may be provided to the user through an airway delivery device that transfer the oxygen enriched gas to the user's mouth and/or nose. In an embodiment, an outlet may include a tube that directs the oxygen toward a user's nose and/or mouth that may not be directly coupled to the user's nose. - Turning to
FIG. 2 , a schematic diagram of an embodiment of an outlet system for an oxygen concentrator is shown.Supply valve 160 may be coupled to outlet tube to control the release of the oxygen enriched gas fromaccumulator 106 to the user. In an embodiment,supply valve 160 is an electromagnetically actuated plunger valve.Supply valve 160 is actuated bycontroller 400 to control the delivery of oxygen enriched gas to a user. Actuation ofsupply valve 160 is not timed or synchronized to the pressure swing adsorption process. Instead, actuation is, in some embodiments, synchronized to the patient's breathing. Additionally,supply valve 160 may have multiple actuations to help establish a clinically effective flow profile for providing oxygen enriched gas. - Oxygen enriched gas in
accumulator 106 passes throughsupply valve 160 intoexpansion chamber 170 as depicted inFIG. 2 . In an embodiment, expansion chamber may include one or more devices capable of being used to determine an oxygen concentration of gas passing through the chamber. Oxygen enriched gas inexpansion chamber 170 builds briefly, through release of gas from accumulator bysupply valve 160, and then is bled through small orifice flow restrictor 175 to flowrate sensor 185 and then toparticulate filter 187. Flow restrictor 175 may be a 0.025 D flow restrictor. Other flow restrictor types and sizes may be used. In some embodiments, the diameter of the air pathway in the housing may be restricted to create restricted air flow.Flow rate sensor 185 may be any sensor capable of assessing the rate of gas flowing through the conduit.Particulate filter 187 may be used to filter bacteria, dust, granule particles, etc. prior to delivery of the oxygen enriched gas to the user. The oxygen enriched gas passes throughfilter 187 toconnector 190 which sends the oxygen enriched gas to the user viaconduit 192 and to pressuresensor 194. - The fluid dynamics of the outlet pathway, coupled with the programmed actuations of
supply valve 160, results in a bolus of oxygen being provided at the correct time and with a flow profile that assures rapid delivery into the patient's lungs without any excessive flow rates that would result in wasted retrograde flow out the nostrils and into the atmosphere. It has been found, in our specific system, that the total volume of the bolus required for prescriptions is equal to 11 mL for each LPM, i.e., 11 mL for a prescription of 1 LPM; 22 mL for a prescription of 2 LPM; 33 mL for a prescription of 3 LPM; 44 mL for a prescription of 4 LPM; 55 mL for a prescription of 5 LPM; etc. This is generally referred to as the LPM equivalent. It should be understood that the LPM equivalent may vary between apparatus due to differences in construction design, tubing size, chamber size, etc. -
Expansion chamber 170 may include one or more oxygen sensors capable of being used to determine an oxygen concentration of gas passing through the chamber. In an embodiment, the oxygen concentration of gas passing throughexpansion chamber 170 is assessed usingoxygen sensor 165. An oxygen sensor is a device capable of detecting oxygen in a gas. Examples of oxygen sensors include, but are not limited to, ultrasonic oxygen sensors, electrical oxygen sensors, and optical oxygen sensors. In one embodiment,oxygen sensor 165 is an ultrasonic oxygen sensor that includesultrasonic emitter 166 andultrasonic receiver 168. In some embodiments,ultrasonic emitter 166 may include multiple ultrasonic emitters andultrasonic receiver 168 may include multiple ultrasonic receivers. In embodiments having multiple emitters/receivers, the multiple ultrasonic emitters and multiple ultrasonic receivers may be axially aligned (e.g., across the gas mixture flow path which may be perpendicular to the axial alignment). - In use, an ultrasonic sound wave (from emitter 166) may be directed through oxygen enriched gas disposed in
chamber 170 toreceiver 168. Ultrasonic sensor assembly may be based on detecting the speed of sound through the gas mixture to determine the composition of the gas mixture (e.g., the speed of sound is different in nitrogen and oxygen). In a mixture of the two gases, the speed of sound through the mixture may be an intermediate value proportional to the relative amounts of each gas in the mixture. In use, the sound at thereceiver 168 is slightly out of phase with the sound sent fromemitter 166. This phase shift is due to the relatively slow velocity of sound through a gas medium as compared with the relatively fast speed of the electronic pulse through wire. The phase shift, then, is proportional to the distance between the emitter and the receiver and the speed of sound through the expansion chamber. The density of the gas in the chamber affects the speed of sound through the chamber and the density is proportional to the ratio of oxygen to nitrogen in the chamber. Therefore, the phase shift can be used to measure the concentration of oxygen in the expansion chamber. In this manner the relative concentration of oxygen in the accumulation chamber may be assessed as a function of one or more properties of a detected sound wave traveling through the accumulation chamber. - In some embodiments,
multiple emitters 166 andreceivers 168 may be used. The readings from theemitters 166 andreceivers 168 may be averaged to cancel errors that may be inherent in turbulent flow systems. In some embodiments, the presence of other gases may also be detected by measuring the transit time and comparing the measured transit time to predetermined transit times for other gases and/or mixtures of gases. - The sensitivity of the ultrasonic sensor system may be increased by increasing the distance between
emitter 166 andreceiver 168, for example to allow several sound wave cycles to occur betweenemitter 166 and thereceiver 168. In some embodiments, if at least two sound cycles are present, the influence of structural changes of the transducer may be reduced by measuring the phase shift relative to a fixed reference at two points in time. If the earlier phase shift is subtracted from the later phase shift, the shift caused by thermal expansion ofexpansion chamber 170 may be reduced or cancelled. The shift caused by a change of the distance betweenemitter 166 andreceiver 168 may be the approximately the same at the measuring intervals, whereas a change owing to a change in oxygen concentration may be cumulative. In some embodiments, the shift measured at a later time may be multiplied by the number of intervening cycles and compared to the shift between two adjacent cycles. Further details regarding sensing of oxygen in the expansion chamber may be found, for example, in U.S. Published Patent Application No. 2009-0065007, published Mar. 12, 2009, and entitled “Oxygen Concentrator Apparatus and Method, which is incorporated herein by reference. -
Flow rate sensor 185 may be used to determine the flow rate of gas flowing through the outlet system. Flow rate sensors that may be used include, but are not limited to: diaphragm/bellows flow meters; rotary flow meters (e.g. Hall Effect flow meters); turbine flow meters; orifice flow meters; and ultrasonic flow meters.Flow rate sensor 185 may be coupled tocontroller 400. The rate of gas flowing through the outlet system may be an indication of the breathing volume of the user. Changes in the flow rate of gas flowing through the outlet system may also be used to determine a breathing rate of the user.Controller 400 may control actuation ofsupply valve 160 based on the breathing rate and/or breathing volume of the user, as assessed byflow rate sensor 185 - In some embodiments,
ultrasonic sensor system 165 and, for example, flowrate sensor 185 may provide a measurement of an actual amount of oxygen being provided. For example, followrate sensor 185 may measure a volume of gas (based on flow rate) provided andultrasonic sensor system 165 may provide the concentration of oxygen of the gas provided. These two measurements together may be used bycontroller 400 to determine an approximation of the actual amount of oxygen provided to the user. - Oxygen enriched gas passes through
flow meter 185 to filter 187.Filter 187 removes bacteria, dust, granule particles, etc. prior to providing the oxygen enriched gas to the user. The filtered oxygen enriched gas passes throughfilter 187 toconnector 190.Connector 190 may be a “Y” connector coupling the outlet offilter 187 topressure sensor 194 andoutlet conduit 192.Pressure sensor 194 may be used to monitor the pressure of the gas passing throughconduit 192 to the user. Changes in pressure, sensed bypressure sensor 194, may be used to determine a breathing rate of a user, as well as the onset of inhalation.Controller 400 may control actuation ofsupply valve 160 based on the breathing rate and/or onset of inhalation of the user, as assessed bypressure sensor 194. In an embodiment,controller 400 may control actuation ofsupply valve 160 based on information provided byflow rate sensor 185 andpressure sensor 194. - Oxygen enriched gas may be provided to a user through
conduit 192. In an embodiment,conduit 192 may be a silicone tube.Conduit 192 may be coupled to a user using anairway coupling member 196, as depicted inFIG. 3 .Airway coupling member 196 may be any device capable of providing the oxygen enriched gas to nasal cavities or oral cavities. Examples of airway coupling members include, but are not limited to: nasal masks, nasal pillows, nasal prongs, nasal cannulas, and mouthpieces. A nasal cannula airway delivery device is depicted inFIG. 3 . During use, oxygen enriched gas fromoxygen concentrator system 100 is provided to the user throughconduit 192 andairway coupling member 196.Airway coupling member 196 is positioned proximate to a user's airway (e.g., proximate to the user's mouth and or nose) to allow delivery of the oxygen enriched gas to the user while allowing the user to breath air from the surroundings. -
Oxygen concentrator system 100 may include at least two canisters, each canister including a gas separation adsorbent. The canisters ofoxygen concentrator system 100 may be disposed formed from a molded housing. In an embodiment,canister system 300 includes twohousing components FIG. 4 . Thehousing components housing components Housing components housing components oxygen concentrator 100. In some embodiments, the twohousings housing components - As shown, valve seats 320, 322, 324, and 326 and
air pathways housing component 310 to reduce the number of sealed connections needed throughout the air flow of theoxygen concentrator 100. In various embodiments, thehousing components oxygen concentrator 100 may form a two-part molded plastic frame that defines twocanisters accumulation chamber 106. - Air pathways/tubing between different sections in
housing components housing components housing components housing components - In some embodiments, prior to
coupling housing components housing components housing components gas separation adsorbents 139, check valves, plugs, processors, power supplies, etc. may be coupled tohousing components - In some embodiments,
apertures 337 leading to the exterior ofhousing components - In some embodiments,
spring baffle 129 may be placed into respective canister receiving portions ofhousing component baffle 129 facing the exit of the canister.Spring baffle 129 may apply force togas separation adsorbent 139 in the canister while also assisting in preventinggas separation adsorbent 139 from entering the exit apertures. Use of aspring baffle 129 may keep the gas separation adsorbent compact while also allowing for expansion (e.g., thermal expansion). Keeping thegas separation adsorbent 139 compact may prevent the gas separation adsorbent from breaking during movement of the oxygen concentrator system 100). - In some embodiments, pressurized air from the
compression system 200 may enterair inlet 306.Air inlet 306 is coupled toinlet conduit 330. Air entershousing component 310 throughinlet 306 travels throughconduit 330, and then tovalve seats FIG. 5 andFIG. 6 depict an end view ofhousing 310.FIG. 5 depicts an end view ofhousing 310 prior to fitting valves tohousing 310.FIG. 6 depicts an end view ofhousing 310 with the valves fitted to thehousing 310. Valve seats 322 and 324 are configured to receiveinlet valves Inlet valve 122 is coupled tocanister 302 andinlet valve 124 is coupled tocanister 304.Housing 310 also includesvalve seats outlet valves Outlet valve 132 is coupled tocanister 302 andoutlet valve 134 is coupled tocanister 304.Inlet valves 122/124 are used to control the passage of air fromconduit 330 to the respective canisters. - In an embodiment, pressurized air is sent into one of
canisters inlet valve 122 is opened whileinlet valve 124 is closed. Pressurized air fromcompression system 200 is forced intocanister 302, while being inhibited from enteringcanister 304 byinlet valve 124. During pressurization ofcanister 302,outlet valve 132 is closed andoutlet valve 134 is opened. Similar to the inlet valves,outlet valves inlet valve seat 322 includes anopening 375 that passes throughhousing 310 intocanister 302. Similarlyvalve seat 324 includes an opening 325 that passes throughhousing 310 intocanister 302. Air fromconduit 330 passes throughopenings 323, or 325 if the respective valve (322 or 324) is open, and enters a canister. - Check
valves 142 and 144 (See,FIG. 4 ) are coupled tocanisters valves canisters openings housing 410. A passage (not shown)links openings conduits canister 302 passes from the canister though opening 542 and intoconduit 342 when the pressure in the canister is sufficient to opencheck valve 142. Whencheck valve 142 is open, oxygen enriched gas flows throughconduit 342 toward the end ofhousing 310. Similarly, oxygen enriched gas produced incanister 304 passes from the canister though opening 544 and intoconduit 344 when the pressure in the canister is sufficient to opencheck valve 144. Whencheck valve 144 is open, oxygen enriched gas flows throughconduit 344 toward the end ofhousing 310. - Oxygen enriched gas from either canister, travels through
conduit conduit 346 formed inhousing 310.Conduit 346 includes openings that couple the conduit toconduit 342,conduit 344 andaccumulator 106. Thus oxygen enriched gas, produced incanister conduit 346 and passes intoaccumulator 106. - After some time the gas separation adsorbent will become saturated with nitrogen and will be unable to separate significant amounts of nitrogen from incoming air. When the gas separation adsorbent in a canister reaches this saturation point, the inflow of compressed air is stopped and the canister is vented to remove nitrogen.
Canister 302 is vented by closinginlet valve 122 and openingoutlet valve 132.Outlet valve 132 releases the vented gas fromcanister 302 into the volume defined by the end ofhousing 310. Foam material may cover the end ofhousing 310 to reduce the sound made by release of gases from the canisters. Similarly,canister 304 is vented by closinginlet valve 124 and openingoutlet valve 134.Outlet valve 134 releases the vented gas fromcanister 304 into the volume defined by the end ofhousing 310. - While
canister 302 is being vented,canister 304 is pressurized to produce oxygen enriched gas in the same manner described above. Pressurization ofcanister 304 is achieved by closingoutlet valve 134 and openinginlet valve 124. The oxygen enriched gas exitscanister 304 throughcheck valve 144. - In an exemplary embodiment, a portion of the oxygen enriched gas may be transferred from
canister 302 tocanister 304 whencanister 304 is being vented of nitrogen. Transfer of oxygen enriched gas fromcanister 302 tocanister 304, during venting ofcanister 304, helps to further purge nitrogen (and other gases) from the canister. Flow of oxygen enriched gas between the canisters is controlled using flow restrictors and valves, as depicted inFIG. 1 . Three conduits are formed inhousing 510 for use in transferring oxygen enriched gas between canisters. As shown inFIG. 7 ,conduit 530 couples canister 302 tocanister 304. Flow restrictor 151 (not shown) is disposed inconduit 530, betweencanister 302 andcanister 304 to restrict flow of oxygen enriched gas during use.Conduit 532 also couplescanister 302 to 304.Conduit 532 is coupled tovalve seat 552 which receivesvalve 152, as shown inFIG. 8 . Flow restrictor 153 (not shown) is disposed inconduit 532, betweencanister Conduit 534 also couplescanister 302 to 304.Conduit 534 is coupled tovalve seat 554 which receivesvalve 154, as shown inFIG. 8 . Flow restrictor 155 (not shown) is disposed in conduit 434, betweencanister vent valves 152/154 work withflow restrictors - Oxygen enriched gas in
accumulator 106 passes throughsupply valve 160 intoexpansion chamber 170 which is formed inhousing 510. An opening (not shown) inhousing 510 couples accumulator 106 to supplyvalve 160. In an embodiment, expansion chamber may include one or more devices capable of being used to determine an oxygen concentration of gas passing through the chamber. - Operation of
oxygen concentrator system 100 may be performed automatically using aninternal controller 400 coupled to various components of the oxygen concentrator system, as described herein.Controller 400 includes one ormore processors 410 andinternal memory 420, as depicted inFIG. 1 . Methods used to operate and monitoroxygen concentrator system 100 may be implemented by program instructions stored inmemory 420 or a carrier medium coupled tocontroller 400, and executed by one ormore processors 410. A non-transitory memory medium may include any of various types of memory devices or storage devices. The term “memory medium” is intended to include an installation medium, e.g., a Compact Disc Read Only Memory (CD-ROM), floppy disks, or tape device; a computer system memory or random access memory such as Dynamic Random Access Memory (DRAM), Double Data Rate Random Access Memory (DDR RAM), Static Random Access Memory (SRAM), Extended Data Out Random Access Memory (EDO RAM), Rambus Random Access Memory (RAM), etc.; or a non-volatile memory such as a magnetic media, e.g., a hard drive, or optical storage. The memory medium may comprise other types of memory as well, or combinations thereof. In addition, the memory medium may be located in a first computer in which the programs are executed, or may be located in a second different computer that connects to the first computer over a network, such as the Internet. In the latter instance, the second computer may provide program instructions to the first computer for execution. The term “memory medium” may include two or more memory mediums that may reside in different locations, e.g., in different computers that are connected over a network. - In some embodiments,
controller 400 includesprocessor 410 that includes, for example, one or more field programmable gate arrays (FPGAs), microcontrollers, etc. included on a circuit board disposed inoxygen concentrator system 100.Processor 410 is capable of executing programming instructions stored inmemory 420. In some embodiments, programming instructions may be built intoprocessor 410 such that a memory external to the processor may not be separately accessed (i.e., thememory 420 may be internal to the processor 410). -
Processor 410 may be coupled to various components ofoxygen concentrator system 100, including, but not limited tocompression system 200, one or more of the valves used to control fluid flow through the system (e.g.,valves oxygen sensor 165,pressure sensor 194, flow rate monitor 180, temperature sensors, fans, and any other component that may be electrically controlled. In some embodiments, a separate processor (and/or memory) may be coupled to one or more of the components. -
Controller 400 is programmed to operateoxygen concentrator system 100 and is further programmed to monitor the oxygen concentrator system for malfunction states. For example, in one embodiment,controller 400 is programmed to trigger an alarm if the system is operating and no breathing is detected by the user for a predetermined amount of time. For example, ifcontroller 400 does not detect a breath for a period of 75 seconds, an alarm LED may be lit and/or an audible alarm may be sounded. If the user has truly stopped breathing, for example, during a sleep apnea episode, the alarm may be sufficient to awaken the user, causing the user to resume breathing. The action of breathing may be sufficient forcontroller 400 to reset this alarm function. Alternatively, if the system is accidently left on whenoutput conduit 192 is removed from the user, the alarm may serve as a reminder for the user to turnoxygen concentrator system 100 off. -
Controller 400 is further coupled tooxygen sensor 165, and may be programmed for continuous or periodic monitoring of the oxygen concentration of the oxygen enriched gas passing throughexpansion chamber 170. A minimum oxygen concentration threshold may be programmed intocontroller 400, such that the controller lights an LED visual alarm and/or an audible alarm to warn the patient of the low concentration of oxygen. -
Controller 400 is also coupled to internal power supply 180 and is capable of monitoring the level of charge of the internal power supply. A minimum voltage and/or current threshold may be programmed intocontroller 400, such that the controller lights an LED visual alarm and/or an audible alarm to warn the patient of low power condition. The alarms may be activated intermittently and at an increasing frequency as the battery approaches zero usable charge. - Further functions of
controller 400 are described in detail in other sections of this disclosure. - A user may have a low breathing rate or depth if relatively inactive (e.g., asleep, sitting, etc.) as assessed by comparing the detected breathing rate or depth to a threshold. The user may have a high breathing rate or depth if relatively active (e.g., walking, exercising, etc.). An active/sleep mode may be assessed automatically and/or the user may manually indicate a respective active or sleep mode by a pressing button for active mode and another button for sleep mode. In some embodiments, a user may toggle a switch from active mode, normal mode, or sedentary mode. The adjustments made by the oxygen concentrator system in response to activating active mode or sleep mode are described in more detail herein.
- The main use of an oxygen concentrator system is to provide supplemental oxygen to a user. Generally, the amount of supplemental oxygen to be provided is assessed by a physician. Typical prescribed amounts of supplemental oxygen may range from about 1 LPM to up to about 10 LPM. The most commonly prescribed amounts are 1 LPM, 2 LPM, 3 LPM, and 4 LPM. Generally, oxygen enriched gas is provided to the use during a breathing cycle to meet the prescription requirement of the user. As used herein the term “breathing cycle” refers to an inhalation followed by an exhalation of a person.
- In order to minimize the amount of oxygen enriched gas that is needed to be produced to meet the prescribed amounts,
controller 400 may be programmed to time delivery of the oxygen enriched gas with the user's inhalations. Releasing the oxygen enriched gas to the user as the user inhales may prevent unnecessary oxygen generation (further reducing power requirements) by not releasing oxygen, for example, when the user is exhaling. Reducing the amount of oxygen required may effectively reduce the amount of air compressing needed for oxygen concentrator 100 (and subsequently may reduce the power demand from the compressors). - Oxygen enriched gas, produced by
oxygen concentrator system 100 is stored in anoxygen accumulator 106 and released to the user as the user inhales. The amount of oxygen enriched gas provided by the oxygen concentrator system is controlled, in part, bysupply valve 160. In an embodiment,supply valve 160 is opened for a sufficient amount of time to provide the appropriate amount of oxygen enriched gas, as assessed bycontroller 400, to the user. In order to minimize the amount of oxygen required to meet the prescription requirements of a user, the oxygen enriched gas may be provided in a bolus when a user's inhalation is first detected. For example, the bolus of oxygen enriched gas may be provided in the first few milliseconds of a user's inhalation. - In an embodiment,
pressure sensor 194 and/or flowrate sensor 185 may be used to determine the onset of inhalation by the user. For example, the user's inhalation may be detected by usingpressure sensor 194. In use, a conduit for providing oxygen enriched gas is coupled to a user's nose and/or mouth (e.g., using a nasal cannula or a face mask). At the onset of an inhalation, the user begins to draw air into their body through the nose and/or mouth. As the air is drawn in, a negative pressure is generated at the end of the conduit, due, in part, to the venturi action of the air being drawn across the end of the delivery conduit.Pressure sensor 194 may be operable to create a signal when a drop in pressure is detected, to signal the onset of inhalation. Upon detection of the onset of inhalation,supply valve 160 is controlled to release a bolus of oxygen enriched gas from theaccumulator 106. - In some embodiments,
pressure sensor 194 may provide a signal that is proportional to the amount of positive or negative pressure applied to a sensing surface. The amount of the pressure change detected bypressure sensor 194 may be used to refine the amount of oxygen enriched gas being provided to the user. For example, if a large negative pressure change is detected bypressure sensor 194, the volume of oxygen enriched gas provided to the user may be increased to take into account the increased volume of gas being inhaled by the user. If a smaller negative pressure is detected, the volume of oxygen enriched gas provided to the user may be decreased to take into account the decreased volume of gas being inhaled by the user. A positive change in the pressure indicates an exhalation by the user and is generally a time that release of oxygen enriched gas is discontinued. Generally while a positive pressure change is sensed,valve 160 remains closed until the next onset of inhalation. - In some embodiments, the sensitivity of the
pressure sensor 194 may be affected by the physical distance of thepressure sensor 194 from the user, especially if the pressure sensor is located inoxygen concentrator system 100 and the pressure difference is detected through the tubing coupling the oxygen concentrator system to the user. In some embodiments, the pressure sensor may be placed in the airway delivery device used to provide the oxygen enriched gas to the user. A signal from the pressure sensor may be provided tocontroller 400 in theoxygen concentrator 100 electronically via a wire or through telemetry such as through BLUETOOTH® (Bluetooth, SIG, Inc. Kirkland, Wash.) or other wireless technology. - In an embodiment, the user's inhalation may be detected by using
flow rate sensor 185. In use, a conduit for providing oxygen enriched gas is coupled to a user's nose and/or mouth (e.g., using a nasal cannula or face mask). At the onset of an inhalation, the user begins to draw air into their body through the nose and/or mouth. As the air is drawn in, an increase in flow of gas passing through conduit is created.Flow rate sensor 185 may be operable to create a signal when an increase in flow rate is detected, to signal the onset of inhalation. Upon detection of the onset of inhalation,supply valve 160 is controlled to release a bolus of oxygen enriched gas from theaccumulator 106. - A user breathing at a rate of 30 breaths per minute (BPM) during an active state (e.g., walking, exercising, etc.) may consume two and one-half times as much oxygen as a user who is breathing at 12 BPM during a sedentary state (e.g., asleep, sitting, etc.).
Pressure sensor 194 and/or flowrate sensor 185 may be used to determine the breathing rate of the user.Controller 400 may process information received frompressure sensor 194 and/or flowrate sensor 185 and determine a breathing rate based on the frequency of the onset of inhalation. The detected breathing rate of the user may be used to adjust the bolus of oxygen enriched gas. The volume of the bolus of oxygen enriched gas may be increased as the users breathing rate increase, and may be decreased as the users breathing rate decreases.Controller 400 may automatically adjust the bolus based on the detected activity state of the user. Alternatively, the user may manually indicate a respective active or sedentary mode by selecting the appropriate option on the control panel of the oxygen concentrator. Alternatively, a user may operatecontroller 400 from a remote electronic device. For example, a user may operate the controller using a smart phone or tablet device. - In some embodiments, if the user's current activity level as assessed using the detected user's breathing rate exceeds a predetermined threshold,
controller 400 may implement an alarm (e.g., visual and/or audio) to warn the user that the current breathing rate is exceeding the delivery capacity of the oxygen concentrator system. For example, the threshold may be set at 20 breaths per minute. - In some embodiments,
controller 400 may operate the oxygen concentrator based on the change in the inspiration breath pressure threshold. The frequency and/or duration of the provided oxygen enriched gas to the user relative to the current frequency and/or duration may be adjusted based on the change in the inspiration breath pressure threshold. Upon determining that the inspiration breath pressure threshold has been lowered, thecontroller 400 may switch the oxygen concentrator to a sedentary mode.Controller 400 may switch the oxygen concentrator to an active mode, when the inspiration breath pressure threshold has been raised. - In some embodiments, as seen in
FIG. 9 , the bolus of provided oxygen enriched gas may include two or more pulses. For example, with a one liter per minute (LPM) delivery rate, the bolus may include two pulses: afirst pulse 556 at approximately 7 cubic centimeters and asecond pulse 558 at approximately 3 cubic centimeters. Other delivery rates, pulse sizes, and number of pulses are also contemplated. For example, at 2 LPMs, the first pulse may be approximately 14 cubic centimeters and a second pulse may be approximately 6 cubic centimeters and at 3 LPMs, the first pulse may be approximately 21 cubic centimeters and a second pulse may be approximately 9 cubic centimeters. In some embodiments, thelarger pulse 556 may be provided when the onset of inhalation is detected (e.g., detected by pressure sensor 194). In some embodiments, the pulses may be provided when the onset of inhalation is detected and/or may be spread time-wise evenly through the breath. In some embodiments, the pulses may be stair-stepped through the duration of the breath. In some embodiments, the pulses may be distributed in a different pattern. Additional pulses may also be used (e.g., 3, 4, 5, etc. pulses per breath). While thefirst pulse 556 is shown to be approximately twice thesecond pulse 558, in some embodiments, thesecond pulse 558 may be larger than thefirst pulse 556. In some embodiments, pulse size and length may be controlled by, for example,supply valve 160 which may open and close in a timed sequence to provide the pulses. A bolus with multiple pulses may have a smaller impact on a user than a bolus with a single pulse. The multiple pulses may also result in less drying of a user's nasal passages and less blood oxygen desaturation. The multiple pulses may also result in less oxygen waste. - In some embodiments, the sensitivity of the
oxygen concentrator 100 may be selectively attenuated to reduce false inhalation detections due to movement of air from a different source (e.g., movement of ambient air). For example, theoxygen concentrator 100 may have two selectable modes—an active mode and an inactive mode. In some embodiments, the user may manually select a mode (e.g., through a switch or user interface). In some embodiments, the mode may be automatically selected by theoxygen concentrator 100 based on a detected breathing rate. For example, theoxygen concentrator 100 may use thepressure sensor 194 to detect a breathing rate of the user. If the breathing rate is above a threshold, theoxygen concentrator 100 may operate in an active mode (otherwise, the oxygen concentrator may operate in an inactive mode). Other modes and thresholds are also contemplated. - In some embodiments, in active mode, the sensitivity of the
pressure sensor 194 may be mechanically, electronically, or programmatically attenuated. For example, during active mode,controller 400 may look for a greater pressure difference to indicate the start of a user breath (e.g., an elevated threshold may be compared to the detected pressure difference to determine if the bolus of oxygen should be released). In some embodiments, thepressure sensor 194 may be mechanically altered to be less sensitive to pressure differences. In some embodiments, an electronic signal from the pressure sensor may be electronically altered to ignore small pressure differences. This can be useful when in active mode. In some embodiments, during the inactive mode the sensitivity of the pressure sensor may be increased. For example, thecontroller 400 may look for a smaller pressure difference to indicate the start of a user breath (e.g., a smaller threshold may be compared to the detected pressure difference to determine if the bolus of oxygen should be released). In some embodiments, with increased sensitivity, the response time for providing the bolus of oxygen during the user's inhalation may be reduced. The increased sensitivity and smaller response time may reduce the size of the bolus necessary for a given flow rate equivalence. The reduced bolus size may also reduce the size and power consumption of theoxygen concentrator 100. - In an embodiment, the bolus profile can be designed to match the profile of a particular user. To do so, an inhalation profile may be generated based on information gathered from
pressure sensor 194 and flowrate sensor 185. An inhalation profile is assessed based on, one or more of the following parameters: the breathing rate of the user; the inhalation volume of the user; the exhalation volume of the user; the inhalation flow rate of the user; and the exhalation flow rate of the user. The breathing rate of the user may be assessed by detecting the onset of inhalation usingpressure sensor 194 or flowrate sensor 185 as previously discussed. Inhalation volume may be assessed by measuring the change in pressure during inhalation and calculating or empirically assessing the inhalation volume based on the change in pressure. Alternatively, inhalation volume may be assessed by measuring the flow rate during inhalation and calculating or empirically assessing the inhalation volume based on the flow rate and the length of the inhalation. Exhalation volume may be assessed in a similar manner using either positive pressure changes during exhalation, or flow rate and exhalation time. Inhalation flow rate of the user is measured from shortly after the onset of inhalation. Detection of the end of inhalation may be from the pressure sensor or the flow rate sensor. When onset of inhalation is detected by the pressure sensor, the onset is characterized by a drop in pressure. When the pressure begins to increase, the inhalation is considered complete. When onset of inhalation is detected by the flow rate sensor, the onset is characterized by an increase in the flow rate. When the flow rate begins to decrease, the inhalation is considered complete. - There is a minimum amount of oxygen necessary for a person to remain conscious. A person who is breathing rapidly is bringing in a lower volume of air in each breath, and thus, requires less oxygen enriched gas per inhalation. While there is some variation from patient to patient, this relationship can be used to establish the mean flow rate for each breath mathematically. By measuring a large population of patients, the profile of the relative flow from onset of inhalation to the onset of exhalation may be established. Using this flow profile as a template, the calculated actual flow based on breathing rate can be adjusted mathematically to a calculated actual flow profile. This profile can be used to adjust the opening and closing of the delivery valve to create an idealized profile for the patient based on their breathing rate. Inhalation profile data gathered from a population of users may be used to create an algorithm that makes the appropriate adjustments based on the detected inhalation profile. Alternatively, a look up table may be used to control valve actuation durations and pulse quantities based on a detected inhalation profile.
- Measuring the inhalation profile of the patient provides a more accurate basis for control of the bolus of oxygen enriched gas being provided to the patient. For example, basing the delivery of oxygen enriched gas on the onset of inhalation may not take into account differences between individual users. For example, people having a similar breathing rate can have different inhalation/exhalation volume, inhalation/exhalation flow rates and, thus, different bolus requirements necessary to produce the prescribed amount of oxygen. In one embodiment, an inhalation profile is created based on the flow rate of air during inhalation and the duration of inhalation. The inhalation profile can then be used as a predictor of the volume of air taken in by a specific user during inhalation. Thus, inhalation profile information can be used to modify the amount of oxygen enriched air provided to the user to ensure that the prescribed level of oxygen is received. The amount of oxygen provided to a user may be adjusted by modifying the frequency and or duration of release of oxygen enriched gas from the accumulator with
supply valve 160. By tracking the inhalation profile of the patient controller adjusts the delivery supply valve actuation to idealize the bolus profile to provide the oxygen at the maximum rate without causing wasteful retrograde flow. - Power for operation of oxygen concentrator system is provided by an internal power supply 180. Having an internal power supply allows portable use of the oxygen concentrator system. In one embodiment, internal power supply 180 includes a lithium ion battery. Lithium ion batteries offer advantages over other rechargeable batteries by being able to provide more power by weight than many other batteries.
- In one embodiment, the compression system, valves, cooling fans and controller may all be powered by an internal power supply. Controller 400 (depicted schematically in
FIG. 1 ) measures the actual output voltage of the internal power supply and adjusts the voltage to the various subsystems to the appropriate level though dedicated circuits on a printed circuit board positioned inside the oxygen concentrator. - In one embodiment,
controller 400 adjusts the operation ofcompressors 305 and 310 based on the oxygen output needs of the user.Controller 400 may assess a preselected prescription for the oxygen concentrator. In the embodiments shown herein, the oxygen concentrator has a switch which is set by the user or the prescribing doctor at the proper prescription rate (1 LPM up to 5 LPM).Controller 400 can assess the position of the switch to determine the prescription for the subject. Based on the prescription of the subject, the controller causes one or more of the compressors to operate to begin production of oxygen. - In many instances, the operation energy of the oxygen concentrator can be optimized by operating the compressors at less than their normal maximum compressor speed. As used herein, the phrase “normal maximum compressor speed” means the speed that the compressor runs when the compressor is supplied with a current and voltage that corresponds with the manufacturer's highest listed current and voltage for proper operation of the compressor.
- At low prescription rates (e.g., 1 LPM) it may not be necessary to run both compressors to produce enough oxygen for the user. In some instances, it may not be necessary to run the compressor(s) at the normal maximum compressor speed.
Controller 400 may be programmed to control the operation of one or more compressors at a percentage of the normal maximum compressor speed, wherein the percentage is assessed based on the preselected prescription. In some instance, the selected percentage is percentage less than 100%. If the prescription setting for the oxygen concentrator is changed,controller 400 may adjust the compressor speed to a different percentage of the normal maximum compressor speed based on changes in the prescription and/or the breathing rate of the user. -
Controller 400 may further assess the breathing rate of the subject. When providing oxygen to the user, the amount of oxygen needed to maintain the proper prescription is based on the breathing rate of the user. When the user has a low breathing rate (e.g., 15 breaths per minute (“bpm”) or less) then the compressor may operate at a first percentage of the normal maximum compressor speed. If the users breathing rate increases, it may be necessary for the compressor to be operated at a second percentage of the normal maximum compressor speed, which is different from the first percentage. In this situation the second percentage will be a higher percentage than the first percentage. - When only one compressor is being used, the controller may arbitrarily select which compressor is operated. The selection of the compressor may be randomized or alternated, to avoid using one compressor more than the other compressor(s). This will help extend the life of the compressors.
- At high prescriptions, (e.g., 3 LPM or more) it may be necessary to run more than one compressor at the same time to provide sufficient oxygen for the user. When two or more compressors are operated at the same time, each of the compressors may be operated at a percentage less than the normal maximum compressor speed. If the breathing rate of the user increases, the speed of each compressor may also be increased. In some embodiments, the compressors may not be capable of moving enough air to produce sufficient oxygen for the patient when operating at 100% of the normal maximum compressor speed.
Controller 400 may be capable of sending a voltage and or current to one or more of the compressors that is above the manufacturer's highest listed current and voltage for proper operation of the compressor. This will cause the compressor(s) to run at a speed above the normal maximum compressor speed. This allows the controller to maintain proper oxygen delivery to the patient, even when the patient's oxygen needs exceed the normal operating parameters of the oxygen concentrator. - In some embodiments, only one compressor may be used to produce the oxygen needed by the patient. The compressor may be operated at a speed that is less than the normal maximum compressor speed. If the activity level of the patient increases the controller may increase the speed of the compressor to increase the production of oxygen. As the speed of the compressor approaches 100% of the normal maximum compressor speed, the controller may start a second compressor before the first compressor reaches 100% of the normal maximum compressor speed. Both compressors may be operated at the same speed, or different speeds. Both compressors may be operated at a speed that is less than the normal maximum compressor speed. The first compressor and the second compressor may be operated at the same percentage of the normal compressor speed.
- In an exemplary embodiment, an oxygen concentrator has two compressors. At a prescription of 1 LPM, a single compressor is operated at about 65% of the normal maximum compressor speed to provide oxygen to the user, if the breathing rate is at about 12-15 bpm. The compressor that is operated is arbitrarily selected by the controller. If the breathing rate of the subject increases above 15 bpm, the compressor speed may be increased to compensate for the increased breathing rate. In this example, the compressor speed remains below 100% of the normal maximum compressor speed at any given breathing rate.
- In the same exemplary system, if the prescription is increased to 2 LPM, a single compressor is operated at about 75% of the normal maximum compressor speed, to provide oxygen to the user, if the breathing rate is at about 12-15 bpm. If the breathing rate of the user increases above 15 bpm, the compressor speed is increased up until the speed of the compressor reaches 85% of the normal maximum compressor speed. At this point the controller turns on the second compressor, and adjust the speed of both compressors, so that both compressors operate at about 65% of the normal maximum compressor speed.
- In the same exemplary system, if the prescription is increased to 3 LPM, both compressors are operated at about 85% of the normal maximum compressor speed, to provide oxygen to the user, if the breathing rate is at about 12-15 bpm. If the breathing rate of the user increases above 15 bpm, the speed of both compressors is increased. If the breathing rate approaches 25 bpm, the compressors may not be able to provide sufficient oxygen when operated at the normal maximum compressor speed. To provide the proper amount of oxygen to the patient, each compressor may be operated at a speed that is greater than the normal maximum compressor speed. Since breathing rates at or above 25 bpm are typically not maintained for long periods of time by the user, the overdriving of the compressors is typically not performed for long.
- This method of controlling the compressors was shown to improve the battery life of the oxygen concentrator. In a prior set up, when the compressors were operated at a single speed, the battery life for the oxygen concentrator was about 2 hours. When the same system was updated using the control method described above, the battery life was increased to 9 hours.
- When using a gas separation adsorbent, oxygen is separated from air by adsorption of molecules other than oxygen onto the gas separation adsorbent. The adsorption process may be enhanced by the choice of the gas separation adsorbent and/or by the design of the canister that contains the gas separation adsorbent.
Oxygen concentrator apparatus 100 may include canisters containing gas separation adsorbent that are designed to produce a steady gas flow (laminar gas flow) or substantially steady gas flow. The canister may be an elongated tube (for example, cylindrical) with a diameter of a first end of the canister being larger than the diameter of the second end of the canister. For example, the canister may be tapered outwardly at the exit end of the canister. Such a canister design, when filled with gas separation adsorbent (for example, zeolite), may produce a gas flow having a Reynolds number ranging from about 10 to about 20 or from about 10 to about 18.FIG. 10 depicts an embodiment of a tapered canister.Canister 600 may includefirst end 602 andsecond end 604. As shownfirst end 602 has a larger diameter thansecond end 604. Side walls ofcanister 600 formfirst end 602 towardsecond end 604. - In some embodiments, the canister may include baffles. One or more baffles may be positioned along the inner wall of the canister at a desired angle relative to the side wall. For example, the baffles may be at about a 90 degree angle relative to the side wall.
FIG. 11A depicts an embodiment ofcanister 606 withbaffles 608.Canister 606 may have the same size and dimension ascanisters FIG. 11B depicts an embodiment oftapered canister 600 withbaffles 608.FIG. 11C depicts a top view of an embodiment ofcanisters baffles 608. Thebaffles 608 may be placed at an angle to the canister 600 (or canister 606) axis in a sequential arrangement to create a helical flow pattern. Helical gas flow may enhance thermal effectiveness and heat transfer without significant pressure drop. Vibration of the canister may be lowered when helical flow pattern is used relative to a pressure drop of a canister without baffles. In some embodiments, the baffles may include holes. The inclusion of baffles in a tapered canister may create of vortex of air flow in the canister. Creating a vortex in the canister may reduce weight per LPM of the device as well as minimize the dead space. This may allow the canister to achieve greater efficacy of conversion with a smaller volume. - In some embodiments, a canister is made from one or more polymers, one or more nonmetals, one or more metal compounds, or mixtures thereof. Examples of polymers include thermosetting polymers, thermoplastic polymers, polyamides, polyesters, polycarbonates, and the like. Examples, of nonmetals include, glass, fused silica, glass fiber, or the like. Examples of metal compounds include aluminum, nickel, copper, metal alloys, or the like. In some embodiments, a canister may be made from polyamides, glass fiber, aluminum or mixtures thereof. For example, the canister may be made of about 60% polyamide and about 40% glass, about 70% polyamide and about 40% glass, or about 80% polyamide and about 20% glass. The canister may include a thin coating of a metal or metal alloy on the inner and/or outer surface of the canister. Films may be deposited on the surface of the canister using physical vapor deposition methods or other methods known in the art to deposit films. An example of physical vapor deposition is sputtering. Using a thin coat of metal or metal alloy may allow fabrication of a light weight canister that does not collapse under pressure. In some embodiments, the canisters are manufactured from materials that all the canister to be disposable.
- Due to the size of the canister in the oxygen concentrator, the quantity of gas separation adsorbent is small, but is capable of producing an adequate quantity of product gas. Since the gas separation adsorbent is optimized for maximum performance for a specific oxygen concentrator (for example, the canister), any significant decrease in capacity of the gas separation adsorbent over time results in decreased product purity. One contributing factor that may lead to a decrease in bed capacity is the adsorption of impurities that do not completely desorb during normal process operation, leading to the accumulation and retention of impurities in the gas separation adsorbent. An example of such an impurity that reduces the adsorption capacity of many zeolites used in air separation is water.
- Some stationary concentrators utilize some means of removing water from the compressed gas before feeding the gas separation adsorbent. Portable concentrators, by the nature of their application, are more likely to be exposed to a wide range of operating conditions including high humidity environments and/or rapid temperature changes that could result in the need for more sophisticated water rejection capabilities than implemented in conventional portable oxygen concentrators. If water is present, either in the form of liquid or vapor, and enters the gas separation adsorbent, the gas adsorbent may adsorb at least some of the water during each adsorption cycle.
- When zeolites are used as the gas separation adsorbent, the energy of adsorption of water is high relative to other types of adsorbent. During the gas separation process not all adsorbed water may be desorbed during evacuation/purge of the beds under typical cycling. Therefore, complete removal of adsorbed water from gas separation adsorbent usually entails applying some sort of energy to the beds, such as thermal, infrared, or microwave, and purging with a dry gas or applying a vacuum to the beds during the regeneration process.
- Although highly effective air drying systems exist in other types of gas separation adsorbent fields, most of these systems consume power, increase size and weight, or reduce system efficiency in a manner detrimental to the stringent power consumption, size/weight, and acoustic noise level requirements of portable concentrators. Using a single process gas separation adsorbent with some portion of the gas separation adsorbent dedicated to impurity processing/rejection is a common method of adding impurity rejection to a gas separation system. Adding canisters containing gas separation adsorbent dedicated to dehydration of the feed stream upstream of the gas separation adsorbent or implementing layered absorbent utilizing desiccants in addition to gas adsorbent suited for the desired gas fractionation are also common methods of adding water rejection capacity to a gas separation system, and can be effective in many circumstances. However, additional canisters add significant size and weight to the concentrator, or in the case of layered absorbents, the desiccant layer displaces volume that could otherwise be used for adsorbent used for highly efficient air separation or the volume of the process columns could be decreased accordingly, and additional power is used to compress gas through the desiccant.
- Desiccants typically used for pre-drying air are also prone to deactivation during constant cycling as well as during shutdown periods, and are often regenerated via applying one of the aforementioned methods. In some cases, the desiccant layer may be advantageous, but also might not be entirely effective at protecting the specialized adsorbents from water damage. By their nature, personal oxygen concentrators, be they portable or stationary, often operate in varied usage modalities rather than in the continuous duty manner of an industrial gas production plant. The duty cycle, storage time between use, and storage environment, can vary widely from unit to unit. For example, home health care providers may have a fleet of units that are stored in warehouses that are not climate controlled while waiting for delivery to patients for use. Similarly, patients may store units in their car or home for a given period of time without use depending on their individual oxygen needs. Thus, care must be used in shutting down and storing units containing gas separation adsorbent that are run on an intermittent basis. Any water (or other impurities) remaining in the desiccant layer(s) or portion of the gas separation adsorbent used for feed gas drying upon shutdown will diffuse over time due to the gradient in chemical potential between the portion of the bed that is used for impurity removal during normal operation and the dry portion of the beds.
- The diffusion coefficient of water in zeolites has Arrhenius type temperature dependence, so if a concentrator is stored in a high temperature environment the rate of intraparticle diffusion will increase exponentially with temperature. The gas phase diffusion rate will increase with increasing temperature as well. Thus, in an oxygen concentrator system it is advantageous to remove as much water as possible from the compressed gas feed stream to prevent deactivation of the highly efficient zeolite, use less desiccant, and minimize the presence of water in the gas separation adsorbent during shutdown. Traditional means of removing water such as coalescing filters and gravity water traps have limited abilities to remove water and can thereby limit the usable service life of oxygen concentrating equipment. The varying operating and storage environments that portable concentrators may be exposed to result in design challenges that more conventional gas separation systems such as gas separation plants might not encounter and must be addressed. As described, more efficient removal of water and/or other impurities from gas separation adsorbent is desired.
- Gas separation adsorbent (for example, zeolites) may have two or more layers that include charged layers. A first layer may include positively charged particles, and a second layer may include negatively charged particles dispersed on top of the negatively charged particles, or vise versa. The negatively charged particles may be evenly or unevenly dispersed on the first layer. For example, water molecules may be electrostatically bound to protons or metal cations in the zeolite. Applying current to the gas separation adsorbent or providing charged air to the gas separation adsorbent may change or disturb the electrostatic charge. For example, the Gouy-Chapman model of electrical double layer may be applied to the canisters. Disruption of the electrostatic charge may release the water from the gas separation adsorbent. The water may be vented from the canister. Removal of a sufficient amount of water may recharge the gas separation adsorbent. Thus, the gas separation adsorbent may be reused. Such treatment of a gas separation adsorbent may extend the life of the gas separation adsorbent and provide economical gas separation adsorbents with good reliability.
- In some embodiments,
oxygen concentrator apparatus 100 may include a canister containing gas separation adsorbent, at least two electrodes and a power supply.FIG. 12 depicts a perspective view of an embodiment of a canister that includes at least twoelectrodes canister 612.FIG. 13 depicts a top view of the canister ofFIG. 12 containinggas separation adsorbent 618.FIG. 14 depicts an embodiment of a canister that includes at least twoelectrodes canister 612.Electrodes power supply 614 bycables 616.Power supply 614 may be a separate power supply (for example, an external power supply or a wall plug) or the same power supply (for example, a battery) for the oxygenconcentrator. Power supply 614 may provide alternating current or direct current toelectrodes -
Electrodes FIG. 14 ,electrodes canister 612. In some embodiments,electrodes canister 612.Electrodes electrodes - In some embodiments,
electrodes electrodes - Supply of power to one of the electrodes, electrically excites the electrode such that current flows between the two electrodes. The current may ionize air flowing between the two electrodes. The ionized air may contact the gas separation adsorbent and ionize water absorbed in the gas separation adsorbent. In some embodiments, contact of the ionized air with bacteria absorbed on the gas separation adsorbent may kill some or all of the bacteria present. In some embodiments, current flowing between
electrodes - During use of an oxygen concentrator system, there are many sources of heat that may cause the temperature of the unit to become elevated. As the temperature of the oxygen concentrator system increases, the components will begin to operate less efficiently. Eventually, if the oxygen concentrator system becomes too hot, some components may become permanently damage, requiring extensive repairs to place the system back into service. In one embodiment, one or more temperature sensors are placed within the body of an oxygen concentrator system. Temperature sensors may be coupled to a controller of the oxygen concentrator system which monitors the internal temperature of the system. If the sensed internal temperature of the oxygen concentrator system exceeds a predetermined threshold, the controller may provide signals that cause the system to shut down until the temperature of the system drops below a predetermined temperature. For example, a controller may initiate a shutdown sequence if the internal temperature of an oxygen concentrator system exceeds 60° C. The oxygen concentrator system may be kept in a shutdown state until the internal temperature of the system falls below 55° C.
- For diagnostic purposes, it may be desirable to check the operation of an oxygen concentrator system by triggering release of the oxygen enriched gas produced by the system. During normal operation, the release of oxygen enriched gas is triggered by a sensed inhalation by the user. For diagnostic testing, it is desirable to be able to trigger the release of oxygen enriched gas produced by an oxygen concentrator system, to test for purity and accuracy of the volume of gas released. In one embodiment, an autopulse mode may be programmed into a controller of an oxygen concentrator system. Autopulse mode may be used to release oxygen enriched gas produced by the oxygen concentrator system without the need to detect an inhalation of a user. In autopulse mode, the controller may provide signals to oxygen concentrator system to release oxygen enriched gas according to predetermined rates. For example, in autopulse mode, the controller may produce pulses of oxygen enriched gas corresponding to breathing rates of 10 bpm, 15 bpm, 20 bpm, 25 bpm, and 30 bpm. Other breathing rates may also be simulated in autopulse mode. In this manner, the operation of the components may be assessed to see if the device is functionally properly.
- When a portable oxygen concentrator, stationary oxygen concentrator, or a hybrid oxygen concentrator is not being used (for example, when the unit is turned off, being shipped, stored, or the like), the gas separation adsorbent may be detrimentally effected and/or deactivated, and thus, the life of the device (gas separation adsorbent) may be effected. For example, when the oxygen concentrator is turned off, pressure in the canister is released. Wet air may be drawn into the canister and be absorbed by the gas separation adsorbent. For example, a device may lose up to 50% of the mean time between failure when the machine is turned off for an extended period of time. Conditioning the device and/or gas separation adsorbent when the oxygen concentrator is in “off time” may extend the life of the device. In some embodiments, the canisters containing gas separation adsorbent may conditioned by storing the gas separation adsorbent or the canister containing the gas separation adsorbent under pressure. For example, the canisters may be pressurized at stored at a pressure ranging from about 5 psi to above 10 psi.
- The controller may monitor and/or assess the pressure of the oxygen concentrator canisters when the canisters are not being used. In a hybrid system, the controller may monitor and determine the pressure of the stationary oxygen concentrator system canisters while the portable oxygen concentrator is being used or vice versa. When the pressure drops below a specified pressure (for example, below 10 psi, below 8 psi, or below 5 psi), the controller will start the compression system (wake-up the machine), and pressurize the canister to the desired pressure. In some embodiments, the canister is pressurized by providing compressed air that has been passed through an adsorbent that dries the water from the air prior to entering the canister. After the canister is pressurized to the desired pressure, the controller will turn the oxygen concentrator off.
- In some embodiments, program instructions in
processor 420 ofcontroller 400 are operable to perform various predefined methods that are used to monitor the pressure of the oxygen concentrator when the oxygen concentrator is in an off state. The controller may automatically assess a state of the oxygen concentrator. For example, the state of the oxygen concentrator may be off or on. Based on the assessed state, the controller may assess a pressure of one or more of the canister. The current pressure of the canister may be stored in memory. The assessed pressure may be determined to be low or normal. For example, the assessed pressure may be compared to a defined pressure range. The defined pressure range may be in a look-up table. In some embodiments, a low or normal pressure is determined using an algorithm. - When the pressure is determined to be low, the controller turns on the compression system and the canister is pressurized to the desired pressure. The speed of the compressor may be adjusted based on the desired pressure and/or the assessed pressure. The controller may continue to monitor the pressure of the canister and when the canister pressure is at the desired pressure, the compression system is turn off. Such monitoring of the canister pressures and pressurizing the canisters as needed during an off time extends the life of the gas separation adsorbent.
- In some embodiments, the life of the gas separation adsorbent may be extended by adjusting the operation of the compressor. During use, the gas separation adsorbent of an oxygen concentrator system will acquire moisture from the air that is contacted with the adsorbent. The moisture in the air reduces the amount of nitrogen that the gas separation adsorbent can remove from the air. When the unit no longer produces oxygen enriched gas having a purity above 85%, the gas separation adsorbent typically needs to be replaced. In an embodiment, a controller of an oxygen concentrator system monitors the oxygen purity and, as it becomes lowers over time, the compressor system is adjusted to provide higher pressure compressed air to the canisters. Generally, gas separation adsorbents will adsorb more nitrogen as the pressure inside the canisters is increased. By operating the compressors at a faster speed, the pressure inside the canisters will increase, leading to higher purity oxygen enriched gas. Operating the compressors at a higher speed will reduce the run time of a battery powered oxygen concentration system, but will allow the user to extend the life of the gas separation adsorbent until the adsorbent is replaced. Oxygen sensors (previously described) are used to assess the purity of the oxygen enriched gas and a controller may alter the operating speed of the compressors to extend the useable life of the gas separation adsorbent.
- In this patent, certain U.S. patents, U.S. patent applications, and other materials (e.g., articles) have been incorporated by reference. The text of such U.S. patents, U.S. patent applications, and other materials is, however, only incorporated by reference to the extent that no conflict exists between such text and the other statements and drawings set forth herein. In the event of such conflict, then any such conflicting text in such incorporated by reference U.S. patents, U.S. patent applications, and other materials is specifically not incorporated by reference in this patent.
- Further modifications and alternative embodiments of various aspects of the invention may be apparent to those skilled in the art in view of this description. Accordingly, this description is to be construed as illustrative only and is for the purpose of teaching those skilled in the art the general manner of carrying out the invention. It is to be understood that the forms of the invention shown and described herein are to be taken as embodiments. Elements and materials may be substituted for those illustrated and described herein, parts and processes may be reversed, and certain features of the invention may be utilized independently, all as would be apparent to one skilled in the art after having the benefit of this description of the invention. Changes may be made in the elements described herein without departing from the spirit and scope of the invention as described in the following claims.
Claims (16)
1-41. (canceled)
42. An oxygen concentrator apparatus, comprising:
one or more canisters, wherein at least one of the canisters comprises a first end having a diameter larger than a diameter of a second end of the canister; and
gas separation adsorbent disposed in at one of the canisters, wherein the gas separation adsorbent separates at least some nitrogen from air in the canister to produce oxygen enriched gas.
43. The oxygen concentrator apparatus of claim 42 , wherein at least one of the canisters comprises one or more baffles.
44. The oxygen concentrator apparatus of claim 42 , wherein at least one canister comprising a first end having a diameter larger than the diameter of a second end of the canister comprises one or more baffles.
45. The oxygen concentrator apparatus of claim 44 , wherein the baffles are configured to redirect flow of gas through the canister.
46. The oxygen concentrator apparatus of claim 42 , wherein at least one canister comprising a first end having a diameter larger than the diameter of a second end of the canister is configured to produce of flow of gas in the canister having a Reynolds number ranging from about 10 to about 20.
47. The oxygen concentrator apparatus of claim 42 , wherein at least one canister comprising a first end having a diameter larger than the diameter of a second end of the canister is configured to produce of flow of gas in the canister having a Reynolds number ranging from about 10 to about 18.
48. The oxygen concentrator apparatus of claim 42 , wherein at least one of the canisters comprises one or more polymers.
49. The oxygen concentrator apparatus of claim 42 , wherein at least one of the canisters comprises one or more polyamides.
50. The oxygen concentrator apparatus of claim 42 , wherein at least one of the canisters is composed of a polymer having a coating comprised of glass.
51. The oxygen concentrator apparatus of claim 42 , wherein at least one of the canisters is composed of a polymer having a coating comprised of one or more metals.
52. The oxygen concentrator apparatus of claim 42 , wherein an internal surface of at least one of the canisters comprises one or more metal coatings, and wherein at least one of the coatings is applied to the canister by sputtering one or more metals on the surface.
53. The oxygen concentrator apparatus of claim 42 , further comprising a compression system comprising at least one compressor coupled to at least one canister.
54. The oxygen concentrator apparatus of claim 42 , further comprising a controller.
55. The oxygen concentrator apparatus of claim 42 , wherein the oxygen concentrator apparatus has a weight of less than about 5 lbs.
56-86. (canceled)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/053,029 US20140137744A1 (en) | 2012-10-12 | 2013-10-14 | Oxygen concentrator systems and methods |
US14/734,211 US9440180B2 (en) | 2012-10-12 | 2015-06-09 | Oxygen concentrator systems and methods |
US15/259,791 US9782557B2 (en) | 2012-10-12 | 2016-09-08 | Oxygen concentrator systems and methods |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261713254P | 2012-10-12 | 2012-10-12 | |
US201361804369P | 2013-03-22 | 2013-03-22 | |
US14/053,029 US20140137744A1 (en) | 2012-10-12 | 2013-10-14 | Oxygen concentrator systems and methods |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/734,211 Continuation US9440180B2 (en) | 2012-10-12 | 2015-06-09 | Oxygen concentrator systems and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
US20140137744A1 true US20140137744A1 (en) | 2014-05-22 |
Family
ID=50477979
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/053,029 Abandoned US20140137744A1 (en) | 2012-10-12 | 2013-10-14 | Oxygen concentrator systems and methods |
US14/734,211 Active US9440180B2 (en) | 2012-10-12 | 2015-06-09 | Oxygen concentrator systems and methods |
US15/259,791 Active US9782557B2 (en) | 2012-10-12 | 2016-09-08 | Oxygen concentrator systems and methods |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/734,211 Active US9440180B2 (en) | 2012-10-12 | 2015-06-09 | Oxygen concentrator systems and methods |
US15/259,791 Active US9782557B2 (en) | 2012-10-12 | 2016-09-08 | Oxygen concentrator systems and methods |
Country Status (8)
Country | Link |
---|---|
US (3) | US20140137744A1 (en) |
EP (3) | EP2906280B1 (en) |
JP (3) | JP2015531310A (en) |
AU (2) | AU2013328916A1 (en) |
BR (1) | BR112015008209A2 (en) |
IL (1) | IL238205A0 (en) |
NZ (1) | NZ707260A (en) |
WO (1) | WO2014059409A1 (en) |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140165830A1 (en) * | 2006-08-28 | 2014-06-19 | Ric Investments, Llc | Oxygen concentration system and method |
US9289717B2 (en) * | 2013-12-18 | 2016-03-22 | Carleton Life Support Systems Inc. | Air drying system for OBOGS |
US9440036B2 (en) | 2012-10-12 | 2016-09-13 | InovaLabs, LLC | Method and systems for the delivery of oxygen enriched gas |
US9440179B2 (en) | 2014-02-14 | 2016-09-13 | InovaLabs, LLC | Oxygen concentrator pump systems and methods |
US9440180B2 (en) | 2012-10-12 | 2016-09-13 | Inova Labs, Llc | Oxygen concentrator systems and methods |
US20170000965A1 (en) * | 2015-06-30 | 2017-01-05 | Vapotherm, Inc. | Nasal cannula for continuous and simultaneous delivery of aerosolized medicament and high flow therapy |
US20170037604A1 (en) * | 2014-03-21 | 2017-02-09 | Siemens Aktiengesellschaft | Method for pressure control in a supply network, device and supply network |
US9649464B2 (en) | 2007-09-06 | 2017-05-16 | Inova Labs, Inc. | Oxygen concentrator apparatus and method having an ultrasonic detector |
US9717876B2 (en) | 2012-10-12 | 2017-08-01 | Inova Labs, Inc. | Dual oxygen concentrator systems and methods |
ES2629065A1 (en) * | 2016-02-05 | 2017-08-07 | Pedro PÉREZ OJEDA | Domestic device for ozonetherapy (Machine-translation by Google Translate, not legally binding) |
US20170281897A1 (en) * | 2014-09-19 | 2017-10-05 | Koninklijke Philips N.V. | Device for providing supplemental oxygen to a subject |
US20170340851A1 (en) * | 2016-05-24 | 2017-11-30 | Silverbow Development, Llc | Oxygen gas concentrator with outlet accumulator |
US20180207373A1 (en) * | 2015-06-03 | 2018-07-26 | Microdose Therapeutx, Inc. | Medical device notification system |
CN109069777A (en) * | 2016-01-21 | 2018-12-21 | 呼吸科技公司 | Modular ventilation system |
WO2019036768A1 (en) * | 2017-08-25 | 2019-02-28 | ResMed Pty Ltd | Methods and apparatus for treating a respiratory disorder |
US10463816B2 (en) | 2014-08-28 | 2019-11-05 | Norton (Waterford) Limited | Compliance-assisting module for an inhaler |
CN112755347A (en) * | 2020-12-31 | 2021-05-07 | 东莞永昇医疗科技有限公司 | Ventilator shutdown control method, ventilator and computer readable storage medium |
US20210154427A1 (en) * | 2019-11-27 | 2021-05-27 | ResMed Asia Pte. Ltd. | Oxygen concentrator with improved sieve bed construction |
US11185656B2 (en) * | 2018-12-05 | 2021-11-30 | Aires Medical LLC | Pulsed pressure swing adsorption system and method |
US11247014B2 (en) * | 2016-02-24 | 2022-02-15 | Teijin Pharma Limited | Oxygen concentrator |
US11291789B2 (en) | 2016-06-30 | 2022-04-05 | Vapotherm, Inc. | Cannula device for high flow therapy |
US20220161274A1 (en) * | 2016-02-08 | 2022-05-26 | Inova Labs, Inc. | System and method of desorbing nitrogen from particles |
US11458274B2 (en) | 2016-05-03 | 2022-10-04 | Inova Labs, Inc. | Method and systems for the delivery of oxygen enriched gas |
US11583650B2 (en) | 2019-06-28 | 2023-02-21 | Vapotherm, Inc. | Variable geometry cannula |
US11724056B2 (en) | 2017-09-08 | 2023-08-15 | Vapotherm, Inc. | Birfurcated cannula device |
US11878115B2 (en) | 2019-09-26 | 2024-01-23 | Vapotherm, Inc. | Internal cannula mounted nebulizer |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017106644A1 (en) * | 2015-12-18 | 2017-06-22 | Inova Labs, Inc. | Vortex canisters for oxvgen-nitrogen separation particles |
WO2019066741A1 (en) | 2017-09-27 | 2019-04-04 | Medicraft Medi̇kal Si̇stemler Anoni̇m Şi̇rketi̇ | Oxygen concentrator |
WO2019191814A1 (en) * | 2018-04-06 | 2019-10-10 | ResMed Pty Ltd | Methods and apparatus for treating a respiratory disorder |
US11260338B2 (en) * | 2018-08-09 | 2022-03-01 | O2 Air-Sea, Llc | Oxygen generation device |
KR102215926B1 (en) * | 2019-06-28 | 2021-02-17 | 한국생산기술연구원 | Method for manufacturing strain gauge with micro crack |
WO2021021027A1 (en) * | 2019-07-31 | 2021-02-04 | ResMed Asia Pte Ltd | Efficient vacuum pressure swing adsorption systems and methods |
KR20220165264A (en) * | 2020-04-06 | 2022-12-14 | 레즈메드 아시아 피티이. 엘티디. | Oxygen generator with moisture management function |
WO2021206631A1 (en) * | 2020-04-08 | 2021-10-14 | ResMed Asia Pte. Ltd. | Methods and apparatus for providing concentrated therapy gas for a respiratory disorder |
CA3189534A1 (en) | 2020-07-16 | 2022-01-20 | Invacare Corporation | System and method for concentrating gas |
CA3189540A1 (en) | 2020-07-16 | 2022-01-20 | Invacare Corporation | System and method for concentrating gas |
CA3189542A1 (en) * | 2020-07-16 | 2022-01-20 | Invacare Corporation | System and method for concentrating gas |
DE102021102859A1 (en) | 2021-02-08 | 2022-08-11 | Tricumed Medizintechnik Gmbh | chip capillary |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4215798A (en) * | 1979-01-15 | 1980-08-05 | Union Carbide Corporation | Container for cryogenic liquid |
Family Cites Families (288)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1338226A (en) | 1970-01-21 | 1973-11-21 | British Oxygen Co Ltd | Lung ventilators |
US4194890A (en) | 1976-11-26 | 1980-03-25 | Greene & Kellogg, Inc. | Pressure swing adsorption process and system for gas separation |
US4496376A (en) * | 1978-01-26 | 1985-01-29 | Litton Systems, Inc. | Variable area molecular sieve container having a thermal control system |
JPS55149620A (en) | 1979-05-11 | 1980-11-21 | Noboru Sato | Oxygen-enriching system having good rise-up characteristic |
US4302224A (en) | 1979-10-12 | 1981-11-24 | Greene & Kellogg, Inc. | Compact oxygen concentrator |
US4342573A (en) | 1979-10-12 | 1982-08-03 | Greene & Kellogg, Incorporated | Compact oxygen concentrator |
US4349357A (en) | 1980-06-23 | 1982-09-14 | Stanley Aviation Corporation | Apparatus and method for fractionating air and other gaseous mixtures |
US4550276A (en) | 1982-06-14 | 1985-10-29 | Michael Callahan | Buss structures for multiscene manual lighting consoles |
US4576616A (en) | 1982-07-27 | 1986-03-18 | Proto-Med. Inc. | Method and apparatus for concentrating oxygen |
US4462398A (en) | 1982-12-03 | 1984-07-31 | Kircaldie, Randal and McNab, Trustee | Respirating gas supply method and apparatus therefor |
US4491459A (en) | 1983-05-04 | 1985-01-01 | Pinkerton Charles J | Portable oxygen enrichment and concentration system |
US4612928A (en) | 1984-08-28 | 1986-09-23 | Tiep Brian L | Method and apparatus for supplying a gas to a body |
JPS61131756A (en) * | 1984-11-30 | 1986-06-19 | 鳥取大学長 | Respiration tuning air sending type concentrated oxygen supply apparatus |
FI81500C (en) | 1985-05-23 | 1990-11-12 | Etelae Haemeen Keuhkovammayhdi | Respiratory Treatment Unit |
US4630482A (en) | 1985-06-17 | 1986-12-23 | John Traina | Method and apparatus for ultrasonic measurements of a medium |
US5052400A (en) | 1986-02-20 | 1991-10-01 | Dietz Henry G | Method and apparatus for using an inhalation sensor for monitoring and for inhalation therapy |
US4698075A (en) | 1986-06-05 | 1987-10-06 | International Oxygen Company, Inc. | Control system for fluid absorption systems and the like |
US5378345A (en) | 1986-07-25 | 1995-01-03 | Ceramatec, Inc. | Ceramic solid electrolyte-based electrochemical oxygen concentrator cell |
US5069688A (en) | 1986-11-06 | 1991-12-03 | The Haser Company Limited | Pressure swing gas separation |
US5024219A (en) | 1987-01-12 | 1991-06-18 | Dietz Henry G | Apparatus for inhalation therapy using triggered dose oxygenator employing an optoelectronic inhalation sensor |
US4859217A (en) | 1987-06-30 | 1989-08-22 | Uop | Process for separating nitrogen from mixtures thereof with less polar substances |
US5099193A (en) | 1987-07-30 | 1992-03-24 | Lutron Electronics Co., Inc. | Remotely controllable power control system |
US4938212A (en) | 1987-10-16 | 1990-07-03 | Puritan-Bennett Corporation | Inspiration oxygen saver |
JPH01104327A (en) | 1987-10-17 | 1989-04-21 | Tokico Ltd | Apparatus for gas separation |
US4968329A (en) | 1987-10-26 | 1990-11-06 | Keefer Bowie | Pressure swing adsorption for concentration of a gas component |
US4938066A (en) | 1988-01-29 | 1990-07-03 | Xecutek Corporation | Ultrasonic apparatus for measuring the speed of sound in a gaseous medium |
US4813979A (en) | 1988-02-02 | 1989-03-21 | The United States Of America As Represented By The Secretary Of The Air Force | Secondary oxygen purifier for molecular sieve oxygen concentrator |
DE3830506A1 (en) | 1988-09-08 | 1990-03-15 | Bergwerksverband Gmbh | METHOD FOR THE EXTRACTION OF NITROGEN FROM OXYGEN AND NITROGEN-CONTAINING GAS MIXTURES BY MEANS OF PRESSURE-CHANGE ADDITIONING ON CARBON MOLECULAR SCREENS |
US5048515A (en) | 1988-11-15 | 1991-09-17 | Sanso David W | Respiratory gas supply apparatus and method |
US4925464A (en) | 1988-11-17 | 1990-05-15 | Ryder International Corporation | Fluid flow switching valve assembly and system |
US5005571A (en) | 1988-11-25 | 1991-04-09 | Dietz Henry G | Mouth nose mask for use with an inhalation therapy and/or breathing monitoring apparatus |
US4927434A (en) | 1988-12-16 | 1990-05-22 | Pall Corporation | Gas component extraction |
US4892566A (en) | 1989-03-22 | 1990-01-09 | Airsep Corporation | Pressure swing adsorption process and system |
GB8907447D0 (en) | 1989-04-03 | 1989-05-17 | Normalair Garrett Ltd | Molecular sieve-type gas separation systems |
US5275642A (en) | 1989-05-17 | 1994-01-04 | Stuart Bassine | Molecular sieve for oxygen concentrator |
US4973339A (en) | 1989-10-18 | 1990-11-27 | Airsep Corporation | Pressure swing absorption process and system for gas separation |
US5060506A (en) | 1989-10-23 | 1991-10-29 | Douglas David W | Method and apparatus for monitoring the content of binary gas mixtures |
US4971049A (en) | 1989-11-06 | 1990-11-20 | Pulsair, Inc. | Pressure sensor control device for supplying oxygen |
US5268021A (en) | 1989-11-20 | 1993-12-07 | Dynotec Corporation | Fluid fractionator |
US5060514A (en) | 1989-11-30 | 1991-10-29 | Puritan-Bennett Corporate | Ultrasonic gas measuring device |
US5129924A (en) | 1989-12-29 | 1992-07-14 | Jerald Schultz | Supplemental oxygen ventilator |
US4971609A (en) | 1990-02-05 | 1990-11-20 | Pawlos Robert A | Portable oxygen concentrator |
CA2054199A1 (en) | 1990-03-02 | 1991-09-03 | Sylvie Eteve | Process for producing oxygen by adsorption separation from air |
US5082473A (en) | 1990-07-23 | 1992-01-21 | Keefer Bowie | Extraction and concentration of a gas component |
US5099837A (en) | 1990-09-28 | 1992-03-31 | Russel Sr Larry L | Inhalation-based control of medical gas |
FR2667800B1 (en) | 1990-10-11 | 1992-12-04 | Air Liquide | ADSORPTION SEPARATION PROCESS, AND ADSORBER. |
DE4105672C1 (en) | 1991-02-22 | 1992-10-08 | Paul Ritzau Pari-Werk Gmbh, 8130 Starnberg, De | Oxygen distributor for inhalation therapy - has stirring chamber with agitator and apertures, with connector opening into chamber |
US5146918A (en) | 1991-03-19 | 1992-09-15 | Medtronic, Inc. | Demand apnea control of central and obstructive sleep apnea |
US5315990A (en) | 1991-12-30 | 1994-05-31 | Mondry Adolph J | Method for delivering incremental doses of oxygen for maximizing blood oxygen saturation levels |
US5682877A (en) | 1991-12-30 | 1997-11-04 | Mondry; Adolph J. | System and method for automatically maintaining a blood oxygen saturation level |
US5226933A (en) | 1992-03-31 | 1993-07-13 | Ohio State University | Pressure swing adsorption system to purify oxygen |
WO1994006541A1 (en) | 1992-09-22 | 1994-03-31 | Arbor Research Corporation | System for separation of oxygen from argon/oxygen mixture |
US5340381A (en) | 1993-05-17 | 1994-08-23 | Vorih Marc L | Operating system for dual-sieve oxygen concentrators |
NO178121C (en) | 1993-10-05 | 1996-01-24 | Ottestad Nils T | Servo gas control valve |
US5351522A (en) | 1993-11-02 | 1994-10-04 | Aequitron Medical, Inc. | Gas sensor |
US5839434A (en) | 1993-11-16 | 1998-11-24 | Invacare Corporation | Method and apparatus for dispensing respiratory gases |
JP2695747B2 (en) | 1993-12-21 | 1998-01-14 | 甲南電機株式会社 | Adsorption type oxygen concentrator |
US5474595A (en) | 1994-04-25 | 1995-12-12 | Airsep Corporation | Capacity control system for pressure swing adsorption apparatus and associated method |
SE503155C2 (en) | 1994-07-28 | 1996-04-01 | Comasec International Sa | Methods and apparatus for functional control of breathing apparatus |
US5469372A (en) | 1994-08-29 | 1995-11-21 | Raymond A. McBrearty | Oxygen concentrator remote monitoring apparatus |
US5593478A (en) | 1994-09-28 | 1997-01-14 | Sequal Technologies, Inc. | Fluid fractionator |
US5764534A (en) | 1994-10-13 | 1998-06-09 | Xilinx, Inc. | Method for providing placement information during design entry |
US5503146A (en) | 1994-10-26 | 1996-04-02 | Devilbiss Health Care, Inc. | Standby control for CPAP apparatus |
US5531807A (en) * | 1994-11-30 | 1996-07-02 | Airsep Corporation | Apparatus and method for supplying oxygen to passengers on board aircraft |
US5549720A (en) | 1994-12-19 | 1996-08-27 | Nellcor Puritan-Bennett Incorporated | Filter |
US5735268A (en) | 1995-06-07 | 1998-04-07 | Salter Labs | Intermitten gas-insufflation apparatus and method therefor |
US5697364A (en) | 1995-06-07 | 1997-12-16 | Salter Labs | Intermittent gas-insufflation apparatus |
US5578115A (en) | 1995-07-24 | 1996-11-26 | Devilbiss Health Care, Inc. | Molecular sieve container for oxygen concentrator |
US5603315A (en) | 1995-08-14 | 1997-02-18 | Reliable Engineering | Multiple mode oxygen delivery system |
FR2743507B1 (en) | 1996-01-16 | 1998-03-06 | Air Liquide | PROCESS FOR THE SEPARATION OF MIXTURES OF OXYGEN AND NITROGEN USING AN ADSORBENT WITH IMPROVED POROSITY |
US5792665A (en) | 1996-05-29 | 1998-08-11 | Morrow, Iii; Donald W. | Oxygen sensing method and hand held analyzer therefore |
US5906672A (en) | 1996-06-14 | 1999-05-25 | Invacare Corporation | Closed-loop feedback control for oxygen concentrator |
US5917135A (en) | 1996-06-14 | 1999-06-29 | Invacare Corporation | Gas concentration sensor and control for oxygen concentrator utilizing gas concentration sensor |
US5733359A (en) | 1996-06-19 | 1998-03-31 | The Boc Group, Inc. | Pressure swing adsorption process turndown control |
US5766310A (en) | 1996-07-19 | 1998-06-16 | Litton Systems Incorporated | Single stage secondary high purity oxygen concentrator |
US5746806A (en) | 1996-08-15 | 1998-05-05 | Nellcor Puritan Bennett Incorporated | Apparatus and method for controlling output of an oxygen concentrator |
FR2752383B1 (en) | 1996-08-16 | 1998-11-06 | Intertechnique Sa | RESPIRATORY PROTECTION EQUIPMENT WITH INDICATION OF OPERATION |
FR2753108B1 (en) | 1996-09-06 | 1998-10-16 | Air Liquide | PROCESS FOR THE SEPARATION OF GASEOUS MIXTURES CONTAINING OXYGEN AND NITROGEN |
US5865174A (en) | 1996-10-29 | 1999-02-02 | The Scott Fetzer Company | Supplemental oxygen delivery apparatus and method |
US5827358A (en) | 1996-11-08 | 1998-10-27 | Impact Mst, Incorporation | Rapid cycle pressure swing adsorption oxygen concentration method and apparatus |
US5890490A (en) | 1996-11-29 | 1999-04-06 | Aylsworth; Alonzo C. | Therapeutic gas flow monitoring system |
ES2230672T3 (en) | 1997-01-31 | 2005-05-01 | Ric Investments, Inc. | PRESSURE MODULATION ABSORPTION SYSTEM INCLUDING A VARIOUS CHAMBER CONTAINER. |
US5858062A (en) | 1997-02-10 | 1999-01-12 | Litton Systems, Inc. | Oxygen concentrator |
US6238971B1 (en) | 1997-02-11 | 2001-05-29 | Micron Technology, Inc. | Capacitor structures, DRAM cell structures, and integrated circuitry, and methods of forming capacitor structures, integrated circuitry and DRAM cell structures |
US5928189A (en) | 1997-04-22 | 1999-07-27 | Phillips; Robert E. | Activity responsive therapeutic delivery system |
US5858063A (en) | 1997-06-03 | 1999-01-12 | Litton Systems, Inc. | Oxygen concentrator with beds' duty cycle control and self-test |
US5961694A (en) | 1997-06-09 | 1999-10-05 | L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | Apparatus and process for the separation of gas mixtures by pressure swing adsorption |
US6065473A (en) | 1997-06-16 | 2000-05-23 | Airsep Corporation | Non-contact gas dispenser and apparatus for use therewith |
US5979440A (en) | 1997-06-16 | 1999-11-09 | Sequal Technologies, Inc. | Methods and apparatus to generate liquid ambulatory oxygen from an oxygen concentrator |
US5988465A (en) | 1997-07-01 | 1999-11-23 | Vitale; Richard | Backpack assembly and method of use |
US5957133A (en) | 1997-07-21 | 1999-09-28 | Hart; William T. | Oral appliance with negative air supply for reducing sleep apnea and snoring |
FR2766384B1 (en) | 1997-07-25 | 1999-09-03 | Air Liquide | REGULATION OF A PSA PROCESS |
US6371114B1 (en) | 1998-07-24 | 2002-04-16 | Minnesota Innovative Technologies & Instruments Corporation | Control device for supplying supplemental respiratory oxygen |
ES2242289T3 (en) | 1997-07-25 | 2005-11-01 | MINNESOTA INNOVATIVE TECHNOLOGIES & INSTRUMENTS CORPORATION (MITI) | CONTROL DEVICE TO SUPPLY SUPPLEMENTARY OXYGEN FOR BREATHING. |
US6532958B1 (en) | 1997-07-25 | 2003-03-18 | Minnesota Innovative Technologies & Instruments Corporation | Automated control and conservation of supplemental respiratory oxygen |
KR19990028153A (en) | 1997-09-30 | 1999-04-15 | 정휘동 | Portable PS Oxygen Generator |
US7204249B1 (en) | 1997-10-01 | 2007-04-17 | Invcare Corporation | Oxygen conserving device utilizing a radial multi-stage compressor for high-pressure mobile storage |
US5988165A (en) | 1997-10-01 | 1999-11-23 | Invacare Corporation | Apparatus and method for forming oxygen-enriched gas and compression thereof for high-pressure mobile storage utilization |
GB9723319D0 (en) | 1997-11-04 | 1998-01-07 | Protector Technologies Bv | Oxygen therapy apparatus |
JPH11228107A (en) | 1998-02-18 | 1999-08-24 | Taizo Nagahiro | Method and device for concentrating gaseous oxygen |
US5968236A (en) | 1998-02-20 | 1999-10-19 | Bassine; Stuart | Valve free oxygen concentrator |
US6382931B1 (en) | 1998-02-24 | 2002-05-07 | Respironics, Inc. | Compressor muffler |
US6017315A (en) | 1998-02-25 | 2000-01-25 | Respironics, Inc. | Patient monitor and method of using same |
US20050121033A1 (en) | 1998-02-25 | 2005-06-09 | Ric Investments, Llc. | Respiratory monitoring during gas delivery |
EP1059999B1 (en) | 1998-02-27 | 2012-10-17 | Praxair Technology, Inc. | Pressure swing adsorption gas separation method, using adsorbents with high intrinsic diffusivity and low pressure ratios |
JPH11244642A (en) * | 1998-03-05 | 1999-09-14 | Nitto Denko Corp | Mixed fluid separation device by adsorbent |
US7329354B2 (en) | 1998-06-09 | 2008-02-12 | Ppt Technologies, Llc | Purification of organic solvent fluids |
SE9802123D0 (en) | 1998-06-15 | 1998-06-15 | Siemens Elema Ab | directional valve |
US6220244B1 (en) | 1998-09-15 | 2001-04-24 | Mclaughlin Patrick L. | Conserving device for use in oxygen delivery and therapy |
FR2783723B1 (en) | 1998-09-25 | 2000-12-29 | Air Liquide | PROCESS FOR TREATING A GAS MIXTURE BY PRESSURE MODULATION ADSORPTION WITH A VARIABLE PRODUCTION RATE |
US6427690B1 (en) | 1998-10-21 | 2002-08-06 | Airsep Corporation | Combined oxygen regulator and conservation device |
US6253767B1 (en) | 1998-12-10 | 2001-07-03 | Robert F. Mantz | Gas concentrator |
JP2000206099A (en) | 1999-01-11 | 2000-07-28 | Ngk Spark Plug Co Ltd | Gas concentration sensor |
JP3641151B2 (en) | 1999-02-04 | 2005-04-20 | 帝人株式会社 | Respirator for therapeutic gas injection |
US6156101A (en) | 1999-02-09 | 2000-12-05 | Air Products And Chemicals, Inc. | Single bed pressure swing adsorption process and system |
US6446630B1 (en) | 1999-02-11 | 2002-09-10 | Sunrise Medical Hhg Inc | Cylinder filling medical oxygen concentrator |
AU3158600A (en) | 1999-03-06 | 2000-09-28 | Glaxo Group Limited | Medicament delivery system |
FR2792210B1 (en) | 1999-04-13 | 2001-09-14 | Air Liquide Sante Int | PORTABLE MEDICAL EQUIPMENT FOR OXYGEN THERAPY AT HOME |
US6536431B1 (en) | 1999-04-26 | 2003-03-25 | Oxygen Leisure Products Limited | Oxygen dispenser |
US6186477B1 (en) | 1999-05-05 | 2001-02-13 | Airsep Corporation | Gas by-pass valve |
US6346139B1 (en) | 1999-05-12 | 2002-02-12 | Respironics, Inc. | Total delivery oxygen concentration system |
US6395065B1 (en) | 1999-05-14 | 2002-05-28 | Respironics, Inc. | Air flow control in a gas fractionalization system and associated method |
CA2274390A1 (en) | 1999-06-10 | 2000-12-10 | Questor Industries Inc. | Multistage chemical separation method and apparatus using pressure swing adsorption |
JP2000354630A (en) | 1999-06-15 | 2000-12-26 | Techno 21:Kk | Oxygen concentration apparatus |
US6192883B1 (en) | 1999-08-03 | 2001-02-27 | Richard L. Miller, Jr. | Oxygen flow control system and method |
US7225809B1 (en) | 1999-11-01 | 2007-06-05 | Ric Investments, Llc | Method and apparatus for monitoring and controlling a medical device |
US7516742B2 (en) | 1999-11-24 | 2009-04-14 | Cardinal Health 207, Inc. | Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing |
JP4258930B2 (en) * | 1999-12-27 | 2009-04-30 | ダイキン工業株式会社 | Dehumidifying / humidifying device, dehumidifying / humidifying device and air conditioner |
US6394089B1 (en) | 2000-01-18 | 2002-05-28 | Northrop Grumman Corporation | Patient ventilator oxygen concentration system |
US6773603B2 (en) | 2000-03-13 | 2004-08-10 | Intellectual Capital Enterprises, Inc. | Chemical removal and suspended solids separation pre-treatment system |
US6558451B2 (en) | 2000-05-10 | 2003-05-06 | Airsep Corporation | Multiple bed pressure swing adsorption method and apparatus |
FR2809329B1 (en) | 2000-05-25 | 2002-08-16 | Air Liquide | PORTABLE OXYGEN CONCENTRATOR |
US6938619B1 (en) | 2000-06-13 | 2005-09-06 | Scott Laboratories, Inc. | Mask free delivery of oxygen and ventilatory monitoring |
US6749405B2 (en) | 2000-06-16 | 2004-06-15 | Stuart Bassine | Reversible pivoting vane rotary compressor for a valve-free oxygen concentrator |
JP4594498B2 (en) * | 2000-07-17 | 2010-12-08 | 帝人株式会社 | Breathing gas supply device |
US6478850B2 (en) | 2000-08-02 | 2002-11-12 | Wearair Oxygen Inc. | Miniaturized wearable oxygen concentrator |
DE60115458T2 (en) | 2000-08-02 | 2006-08-17 | Wearair Oxygen Inc., Kelowna | MINIATURIZED PORTABLE OXYGEN CONCENTRATOR |
US6651658B1 (en) * | 2000-08-03 | 2003-11-25 | Sequal Technologies, Inc. | Portable oxygen concentration system and method of using the same |
US6691702B2 (en) | 2000-08-03 | 2004-02-17 | Sequal Technologies, Inc. | Portable oxygen concentration system and method of using the same |
WO2002020136A1 (en) | 2000-09-06 | 2002-03-14 | Colorado Altitude Training Llc | Altitude simulation method and system |
US7122073B1 (en) | 2000-09-18 | 2006-10-17 | Praxair Technology, Inc. | Low void adsorption systems and uses thereof |
JP4246365B2 (en) | 2000-09-21 | 2009-04-02 | 日本特殊陶業株式会社 | Oxygen concentrator, its control device, and recording medium |
JP4293581B2 (en) | 2000-09-21 | 2009-07-08 | 日本特殊陶業株式会社 | Oxygen concentrator, control device, and recording medium |
US6626175B2 (en) | 2000-10-06 | 2003-09-30 | Respironics, Inc. | Medical ventilator triggering and cycling method and mechanism |
US6824590B2 (en) | 2000-11-07 | 2004-11-30 | Air Products And Chemicals, Inc. | Use of lithium-containing fau in air separation processes including water and/or carbon dioxide removal |
CA2360717C (en) | 2000-11-07 | 2005-12-06 | Air Products And Chemicals, Inc. | Use of lithium-containing fau in air separation processes including water and/or carbon dioxide removal |
AU2002215752A1 (en) | 2000-12-08 | 2002-06-18 | Denis Connor | Methods and apparatuses for gas separation by pressure swing adsorption with partial gas product feed to fuel cell power source |
CA2329475A1 (en) * | 2000-12-11 | 2002-06-11 | Andrea Gibbs | Fast cycle psa with adsorbents sensitive to atmospheric humidity |
US6790260B2 (en) | 2000-12-20 | 2004-09-14 | Praxair Technology, Inc. | Enhanced rate PSA process |
US6511526B2 (en) | 2001-01-12 | 2003-01-28 | Vbox, Incorporated | Pressure swing adsorption gas separation method and apparatus |
JP2002253675A (en) | 2001-02-28 | 2002-09-10 | Teijin Ltd | Apparatus for concentrating oxygen for medical use |
US6484721B1 (en) | 2001-06-27 | 2002-11-26 | Chad Therapeutics, Inc. | Pneumatic oxygen conserving device |
US20030006024A1 (en) | 2001-07-05 | 2003-01-09 | Ta-Chin Wang | Radiator for a motor of an air compressor |
US6551384B1 (en) | 2001-07-05 | 2003-04-22 | Praxair Technology, Inc. | Medical oxygen concentrator |
US6527830B1 (en) | 2001-10-03 | 2003-03-04 | Praxair Technology, Inc. | Pressure swing adsorption process for co-producing nitrogen and oxygen |
US6896721B1 (en) | 2001-10-03 | 2005-05-24 | Thomas Industries Inc. | Motor start-up unloading in an oxygen concentrator |
US20030140924A1 (en) | 2001-11-06 | 2003-07-31 | Aylsworth Alonzo C. | Therapeutic gas conserver and control |
US20030111081A1 (en) | 2001-12-19 | 2003-06-19 | Gupta Parshotam C. | Detachable nasal cannula assembly |
US6764534B2 (en) | 2002-01-31 | 2004-07-20 | Airsep Corporation | Portable oxygen concentrator |
AU2003213391A1 (en) | 2002-03-05 | 2003-09-16 | Teijin Limited | Oxygen enricher |
JP2003286008A (en) * | 2002-03-28 | 2003-10-07 | Ngk Spark Plug Co Ltd | Oxygen concentrator |
US6755895B2 (en) | 2002-04-09 | 2004-06-29 | H2Gen Innovations, Inc. | Method and apparatus for pressure swing adsorption |
DE60312837T2 (en) | 2002-04-24 | 2007-12-06 | Airsep Corp. | OXYGEN CONCENTRATOR WITH REDUCED NOISE LEVEL |
US6866041B2 (en) | 2002-05-14 | 2005-03-15 | Evolution, Inc. | Oxygen concentrating aroma mixing breathable air delivery apparatus and method |
US6702880B2 (en) | 2002-05-17 | 2004-03-09 | Porous Media Corporation | Inlet silencer/filter for an oxygen concentrator |
US6669758B1 (en) | 2002-06-27 | 2003-12-30 | Carleton Life Support Systems, Inc. | Variable inlet air restriction for composition control of product gas |
US6605136B1 (en) | 2002-07-10 | 2003-08-12 | Air Products And Chemicals, Inc. | Pressure swing adsorption process operation and optimization |
US6712876B2 (en) | 2002-08-27 | 2004-03-30 | Litton Systems, Inc. | Oxygen concentrator system with altitude compensation |
US6712877B2 (en) | 2002-08-27 | 2004-03-30 | Litton Systems, Inc. | Oxygen concentrator system |
US6740146B2 (en) | 2002-09-12 | 2004-05-25 | Edward L. Simonds | Oxygen concentrator |
MXPA05003815A (en) | 2002-10-09 | 2005-07-13 | Compumedics Ltd | Method and apparatus for maintaining and monitoring sleep quality during therapeutic treatments. |
US6699307B1 (en) | 2002-10-11 | 2004-03-02 | H2Gen Innovations, Inc. | High recovery PSA cycles and apparatus with reduced complexity |
KR200337953Y1 (en) | 2002-10-18 | 2004-01-07 | 마츠시타 덴끼 산교 가부시키가이샤 | Oxygen enrichment apparatus |
US6889726B2 (en) | 2002-10-25 | 2005-05-10 | Invacare Corporation | Method and apparatus for filling portable high pressure cylinders with respiratory oxygen |
US6802889B2 (en) | 2002-12-05 | 2004-10-12 | Air Products And Chemicals, Inc. | Pressure swing adsorption system for gas separation |
WO2004052438A1 (en) | 2002-12-06 | 2004-06-24 | Fisher & Paykel Healthcare Limited | Mouthpiece |
US7011092B2 (en) | 2002-12-12 | 2006-03-14 | Airsep Corporation | Portable hypoxic apparatus |
US20040141874A1 (en) | 2003-01-15 | 2004-07-22 | Phillip Mullinax | System and apparatus for ozonating air and water for animal confinement houses |
WO2004065293A2 (en) * | 2003-01-15 | 2004-08-05 | Phillip Mullinax | Ozonating system and method of using the same |
JP4301452B2 (en) | 2003-02-18 | 2009-07-22 | サンビオー2 カンパニー,リミティド | Gas concentration method and apparatus |
US20040182394A1 (en) | 2003-03-21 | 2004-09-23 | Alvey Jeffrey Arthur | Powered air purifying respirator system and self contained breathing apparatus |
FR2853257B1 (en) | 2003-04-02 | 2006-05-26 | Air Liquide | OXYGEN-ENRICHED GAS FLOW PRODUCTION SYSTEM AND METHOD FOR FEEDING AIRCRAFT OCCUPANTS |
ES2600525T3 (en) | 2003-04-21 | 2017-02-09 | Teijin Pharma Limited | Oxygen concentration system to generate oxygen enriched gas |
DE10318384B4 (en) | 2003-04-23 | 2007-11-22 | Dräger Medical AG & Co. KG | Incubator with an oxygen dosage |
US6935460B2 (en) | 2003-05-21 | 2005-08-30 | Airsep Corporation | Noise muffler for oxygen concentrator |
US6918953B2 (en) | 2003-07-09 | 2005-07-19 | H2Gen Innovations, Inc. | Modular pressure swing adsorption process and apparatus |
WO2005014145A1 (en) | 2003-08-12 | 2005-02-17 | Jej Co., Ltd. | Gas concentrator |
AU2004266693B2 (en) | 2003-08-18 | 2011-03-10 | Breathe Technologies, Inc | Method and device for non-invasive ventilation with nasal interface |
AU2004266540B9 (en) * | 2003-08-26 | 2010-04-01 | Teijin Limited | Oxygen-concentrating device |
EP1663433B1 (en) | 2003-09-02 | 2011-07-27 | Airsep Corporation | Sound enclosure for portable oxygen concentrators |
JP4409240B2 (en) | 2003-09-19 | 2010-02-03 | 山陽電子工業株式会社 | Resin structure, PSA gas separation device, and assembly method of PSA gas separation device |
US7066985B2 (en) | 2003-10-07 | 2006-06-27 | Inogen, Inc. | Portable gas fractionalization system |
CA2540599C (en) | 2003-10-07 | 2013-09-03 | Inogen, Inc. | Portable gas fractionalization system |
US20050072423A1 (en) | 2003-10-07 | 2005-04-07 | Deane Geoffrey Frank | Portable gas fractionalization system |
US7135059B2 (en) | 2003-10-07 | 2006-11-14 | Inogen, Inc. | Portable gas fractionalization system |
US20070135724A1 (en) | 2003-10-17 | 2007-06-14 | Ujhazy Anthony J | Methods and apparatus for heart failure treatment |
JP4709529B2 (en) | 2003-10-28 | 2011-06-22 | 日本特殊陶業株式会社 | Oxygen concentrator |
US8584676B2 (en) | 2003-11-19 | 2013-11-19 | Immediate Response Technologies | Breath responsive filter blower respirator system |
US7114932B1 (en) | 2004-01-22 | 2006-10-03 | Stuart Bassine | Valve-free oxygen concentrator featuring reversible compressors |
ES2287816T3 (en) | 2004-01-22 | 2007-12-16 | Air Products And Chemicals, Inc. | MEDICAL OXYGEN CONCENTRATOR WITH DUAL MODE. |
US7273051B2 (en) | 2004-01-22 | 2007-09-25 | Air Products And Chemicals, Inc. | Dual mode medical oxygen concentrator |
WO2005082107A2 (en) | 2004-02-26 | 2005-09-09 | Ameriflo, Inc. | Method and apparatus for regulating fluid flow or conserving fluid flow |
JP2005245825A (en) | 2004-03-05 | 2005-09-15 | Teijin Pharma Ltd | Respirable gas supply apparatus |
US6981502B2 (en) | 2004-04-01 | 2006-01-03 | Numask, Inc. | Respiratory mask having intraoral mouthpiece with large sealing area and multiple sealing configuration |
US7007694B2 (en) | 2004-05-21 | 2006-03-07 | Acoba, Llc | Nasal cannula |
US7279029B2 (en) | 2004-05-21 | 2007-10-09 | Air Products And Chemicals, Inc. | Weight-optimized portable oxygen concentrator |
CA2568369A1 (en) | 2004-06-04 | 2005-12-15 | Inogen, Inc. | Systems and methods for delivering therapeutic gas to patients |
US7222624B2 (en) | 2004-07-02 | 2007-05-29 | Praxair Technology, Inc. | Dual sensor oxygen therapy device |
US7013898B2 (en) | 2004-07-09 | 2006-03-21 | Praxair Technology, Inc. | Nasal pressure sensor oxygen therapy device |
JP4312749B2 (en) | 2004-08-30 | 2009-08-12 | 日本特殊陶業株式会社 | Oxygen concentrator |
US20060042634A1 (en) | 2004-08-31 | 2006-03-02 | Nalagatla Anil K | Device for connecting a cannula to a medical effector system |
EP1804874A2 (en) | 2004-10-12 | 2007-07-11 | Airsep Corporation | Oxygen concentrator with variable temperature and pressure sensing control means |
JP4898689B2 (en) | 2004-10-12 | 2012-03-21 | エアーセップ・コーポレーション | Small portable oxygen concentrator |
US7455717B2 (en) | 2004-10-25 | 2008-11-25 | Invacare Corporation | Apparatus and method of providing concentrated product gas |
US20090199855A1 (en) | 2004-11-01 | 2009-08-13 | Davenport James M | System and method for conserving oxygen delivery while maintaining saturation |
DE202005015106U1 (en) | 2004-12-01 | 2006-02-09 | Toussaint, Winfried, Dr. | Infinitely adjustable mandibular groin splint for the treatment of snoring and obstructive sleep apnea |
US7171963B2 (en) | 2005-02-09 | 2007-02-06 | Vbox, Incorporated | Product pump for an oxygen concentrator |
US7604005B2 (en) | 2005-02-09 | 2009-10-20 | Vbox Incorporated | Adsorbent cartridge for oxygen concentrator |
US7866315B2 (en) | 2005-02-09 | 2011-01-11 | Vbox, Incorporated | Method and apparatus for controlling the purity of oxygen produced by an oxygen concentrator |
US7954490B2 (en) | 2005-02-09 | 2011-06-07 | Vbox, Incorporated | Method of providing ambulatory oxygen |
US20060174875A1 (en) | 2005-02-09 | 2006-08-10 | Vbox, Incorporated | Ambulatory oxygen concentrator containing a power pack |
US20060174871A1 (en) | 2005-02-09 | 2006-08-10 | Vbox, Incorporated | Ambulatory oxygen concentrator with high efficiency adsorbent |
US7766010B2 (en) | 2005-02-09 | 2010-08-03 | Vbox, Incorporated | Method of controlling the rate of oxygen produced by an oxygen concentrator |
US20060174877A1 (en) | 2005-02-09 | 2006-08-10 | Vbox, Incorporated | Portable oxygen concentrator with a docking station |
US7121276B2 (en) | 2005-02-09 | 2006-10-17 | Vbox, Incorporated | Personal oxygen concentrator |
US7431032B2 (en) | 2005-02-09 | 2008-10-07 | Vbox Incorporated | Low power ambulatory oxygen concentrator |
US8020553B2 (en) | 2005-02-09 | 2011-09-20 | Vbox, Incorporated | Ambulatory oxygen concentrator containing a three phase vacuum separation system |
WO2006091723A2 (en) | 2005-02-23 | 2006-08-31 | Inogen Inc. | Method and apparatus for controlling a gas fractionalization apparatus |
US7329304B2 (en) | 2005-04-05 | 2008-02-12 | Respironics Oxytec, Inc. | Portable oxygen concentrator |
US7368005B2 (en) | 2005-04-05 | 2008-05-06 | Respironics Oxytec, Inc. | Portable oxygen concentrator |
US7402193B2 (en) | 2005-04-05 | 2008-07-22 | Respironics Oxytec, Inc. | Portable oxygen concentrator |
JP4758129B2 (en) * | 2005-04-07 | 2011-08-24 | 日本特殊陶業株式会社 | Oxygen concentrator |
ITRM20050217A1 (en) | 2005-05-06 | 2006-11-07 | Ginevri S R L | PROCEDURE FOR NASAL VENTILATION AND ITS APPARATUS, IN PARTICULAR FOR NEONATAL FLOW-SYNCHRONIZED ASSISTED VENTILATION. |
US7708802B1 (en) | 2005-05-23 | 2010-05-04 | Inogen, Inc. | Gas fractionalization apparatus with built-in administrative and self-diagnostic functions |
US7565907B2 (en) | 2005-06-17 | 2009-07-28 | Salter Labs | Nasal and oral cannula having two capabilities and method of producing same |
US20070044799A1 (en) | 2005-07-08 | 2007-03-01 | Hete Bernie F | Modular oxygen regulator system and respiratory treatment system |
US7510601B2 (en) | 2005-12-20 | 2009-03-31 | Air Products And Chemicals, Inc. | Portable medical oxygen concentrator |
US7686870B1 (en) | 2005-12-29 | 2010-03-30 | Inogen, Inc. | Expandable product rate portable gas fractionalization system |
US7758672B2 (en) | 2006-01-26 | 2010-07-20 | Oxus Co., Ltd. | Apparatus of oxygen concentration system and method thereof |
KR100741307B1 (en) | 2006-05-24 | 2007-07-23 | 주식회사 옥서스 | The apparatus of oxygen concentration system |
JP2007195820A (en) | 2006-01-27 | 2007-08-09 | Terumo Corp | Oxygen concentrator and method of its use |
DE102007006689B4 (en) | 2006-03-31 | 2021-07-29 | Löwenstein Medical Technology S.A. | Device and method for detecting obstruction during apnea phases by means of an additional pressure level |
US20070283958A1 (en) | 2006-05-23 | 2007-12-13 | Ray Naghavi | Positive airway pressure device |
US7771511B2 (en) | 2006-08-28 | 2010-08-10 | Ric Investments, Llc | Oxygen concentration system and method |
US8322339B2 (en) | 2006-09-01 | 2012-12-04 | Nellcor Puritan Bennett Llc | Method and system of detecting faults in a breathing assistance device |
US20080066739A1 (en) | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
US20080078392A1 (en) | 2006-09-29 | 2008-04-03 | Pelletier Dana G | Breath detection system |
US8016918B2 (en) | 2006-10-04 | 2011-09-13 | Air Products And Chemicals, Inc. | Performance stability in rapid cycle pressure swing adsorption systems |
US7857894B2 (en) | 2006-10-10 | 2010-12-28 | Inogen, Inc. | Adsorbent bed pressure balancing for a gas concentrator |
US7780768B2 (en) | 2006-11-28 | 2010-08-24 | Inogen, Inc. | Gas concentrator with improved water rejection capability |
US8020558B2 (en) | 2007-01-26 | 2011-09-20 | Cs Medical, Inc. | System for providing flow-targeted ventilation synchronized to a patient's breathing cycle |
US20080223367A1 (en) | 2007-01-29 | 2008-09-18 | Cox Brian J | Method and apparatus for treating airway obstruction |
US20080202508A1 (en) * | 2007-02-27 | 2008-08-28 | Mcclain Michael S | Oxygen concentrator system |
KR101511803B1 (en) * | 2007-05-07 | 2015-04-13 | 데이진 화-마 가부시키가이샤 | Oxygen enricher |
US8794235B2 (en) | 2007-06-08 | 2014-08-05 | Ric Investments, Llc | System and method for treating ventilatory instability |
US7901485B2 (en) | 2007-07-11 | 2011-03-08 | Mccutchen Co. | Radial counterflow carbon capture and flue gas scrubbing |
JP4816590B2 (en) * | 2007-08-10 | 2011-11-16 | 株式会社Ihi | Method for shutting down oxygen concentrator and oxygen concentrator |
US20090065007A1 (en) | 2007-09-06 | 2009-03-12 | Wilkinson William R | Oxygen concentrator apparatus and method |
US20090107501A1 (en) | 2007-10-24 | 2009-04-30 | Ana Krieger | System and method of monitoring respiratory airflow and oxygen concentration |
US20090107500A1 (en) | 2007-10-25 | 2009-04-30 | Sequal Technologies, Inc. | Portable Oxygen Concentrator System and Method Including Concentrated Oxygen Flow Delivery |
US20090145428A1 (en) | 2007-12-05 | 2009-06-11 | Sequal Technologies, Inc. | System and Method for Controlling Supply of Oxygen Based on Breathing Rate |
US20090211448A1 (en) | 2008-02-21 | 2009-08-27 | Mcclain Michael S | Oxygen concentrator water separating system |
US7722698B2 (en) | 2008-02-21 | 2010-05-25 | Delphi Technologies, Inc. | Method of determining the purity of oxygen present in an oxygen-enriched gas produced from an oxygen delivery system |
US20090241956A1 (en) | 2008-03-27 | 2009-10-01 | Nellcor Puritan Bennett Llc | Method for controlling delivery of breathing gas to a patient using multiple ventilation parameters |
US20090306529A1 (en) | 2008-06-06 | 2009-12-10 | Salter Labs | Adaptive temperature sensor for breath monitoring device |
US9278185B2 (en) | 2008-09-04 | 2016-03-08 | Caire Inc. | System and method for controlling bolus pulse duration based on inspiratory time in an oxygen concentation system |
US8707954B2 (en) | 2008-10-09 | 2014-04-29 | Daniel A. McCarthy | Air/oxygen supply system and method |
WO2010054323A2 (en) | 2008-11-10 | 2010-05-14 | Sequal Technologies, Inc. | Medical ventilator system and method using oxygen concentrators |
US7960857B2 (en) | 2008-12-02 | 2011-06-14 | General Electric Company | System and method for vehicle based uninterruptable power supply |
US8608827B2 (en) | 2008-12-22 | 2013-12-17 | Koninklijke Philips N.V. | Portable and stationary oxygen concentrator system |
WO2010132853A2 (en) | 2009-05-15 | 2010-11-18 | Sequal Technologies Inc. | Apparatus and methods for treating sleep related disorders |
US8695600B2 (en) | 2009-07-22 | 2014-04-15 | Vbox, Incorporated | Method of separating and distributing oxygen |
US9695806B2 (en) | 2009-07-22 | 2017-07-04 | Vbox, Incorporated | Method of controlling gaseous fluid pump |
EP2485794A4 (en) * | 2009-10-05 | 2013-12-18 | Separation Design Group Llc | Ultra rapid cycle portable oxygen concentrator |
US20110186054A1 (en) | 2010-02-01 | 2011-08-04 | Bryan Boyd | Apparatus for Facilitating Respiration During Nasal Congestion, and Related Methods |
US9974918B2 (en) | 2010-04-07 | 2018-05-22 | Caire Inc. | Portable oxygen delivery device |
US20110315140A1 (en) | 2010-06-29 | 2011-12-29 | Precision Medical, Inc. | Portable oxygen concentrator |
US8603228B2 (en) | 2010-09-07 | 2013-12-10 | Inova Labs, Inc. | Power management systems and methods for use in an oxygen concentrator |
US20120055483A1 (en) | 2010-09-07 | 2012-03-08 | Wilkinson William R | Shutdown system and method for an oxygen concentrator |
US20120055478A1 (en) | 2010-09-07 | 2012-03-08 | Wilkinson William R | Positive pressure therapy systems and methods |
US20120055480A1 (en) | 2010-09-07 | 2012-03-08 | Wilkinson William R | Ventilator systems and methods |
US20120055477A1 (en) | 2010-09-07 | 2012-03-08 | Wilkinson William R | Oxygen concentrator apparatus configured for high altitude use |
US8616207B2 (en) | 2010-09-07 | 2013-12-31 | Inova Labs, Inc. | Oxygen concentrator heat management system and method |
US8440004B2 (en) | 2010-12-30 | 2013-05-14 | Inogen, Inc. | Advanced portable oxygen concentrator |
US9592360B2 (en) | 2011-04-22 | 2017-03-14 | Inogen, Inc. | Gas concentrator with removable cartridge adsorbent beds |
EP2906280B1 (en) | 2012-10-12 | 2018-09-26 | Inova Labs, Inc. | Oxygen concentrator systems and methods |
NZ707064A (en) | 2012-10-12 | 2017-11-24 | Inova Labs Inc | Method and systems for the delivery of oxygen enriched gas |
US9138557B2 (en) | 2012-10-12 | 2015-09-22 | Inova Labs, Inc. | Dual oxygen concentrator systems and methods |
-
2013
- 2013-10-14 EP EP13844697.6A patent/EP2906280B1/en active Active
- 2013-10-14 BR BR112015008209A patent/BR112015008209A2/en not_active Application Discontinuation
- 2013-10-14 NZ NZ707260A patent/NZ707260A/en unknown
- 2013-10-14 EP EP23174676.9A patent/EP4249104A3/en active Pending
- 2013-10-14 JP JP2015536981A patent/JP2015531310A/en active Pending
- 2013-10-14 WO PCT/US2013/064823 patent/WO2014059409A1/en active Application Filing
- 2013-10-14 EP EP18191040.7A patent/EP3578220B1/en active Active
- 2013-10-14 AU AU2013328916A patent/AU2013328916A1/en not_active Abandoned
- 2013-10-14 US US14/053,029 patent/US20140137744A1/en not_active Abandoned
-
2015
- 2015-04-12 IL IL238205A patent/IL238205A0/en unknown
- 2015-06-09 US US14/734,211 patent/US9440180B2/en active Active
-
2016
- 2016-09-08 US US15/259,791 patent/US9782557B2/en active Active
-
2018
- 2018-03-02 JP JP2018037506A patent/JP6745828B2/en active Active
- 2018-05-01 AU AU2018203024A patent/AU2018203024A1/en not_active Abandoned
-
2020
- 2020-08-04 JP JP2020132077A patent/JP7086146B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4215798A (en) * | 1979-01-15 | 1980-08-05 | Union Carbide Corporation | Container for cryogenic liquid |
Cited By (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140165830A1 (en) * | 2006-08-28 | 2014-06-19 | Ric Investments, Llc | Oxygen concentration system and method |
US9095811B2 (en) * | 2006-08-28 | 2015-08-04 | Ric Investments, Llc | Oxygen concentration system and method |
US9649465B2 (en) | 2007-09-06 | 2017-05-16 | Inova Labs, Inc. | Oxygen concentrator apparatus and method having variable operation modes |
US9649464B2 (en) | 2007-09-06 | 2017-05-16 | Inova Labs, Inc. | Oxygen concentrator apparatus and method having an ultrasonic detector |
US9956370B2 (en) | 2007-09-06 | 2018-05-01 | Inova, Labs, LLC. | Oxygen concentrator apparatus and method having flow restricted coupling of the canisters |
US9440036B2 (en) | 2012-10-12 | 2016-09-13 | InovaLabs, LLC | Method and systems for the delivery of oxygen enriched gas |
US9440180B2 (en) | 2012-10-12 | 2016-09-13 | Inova Labs, Llc | Oxygen concentrator systems and methods |
US9717876B2 (en) | 2012-10-12 | 2017-08-01 | Inova Labs, Inc. | Dual oxygen concentrator systems and methods |
US11684744B2 (en) | 2012-10-12 | 2023-06-27 | Inova Labs, Inc. | Method and systems for the delivery of oxygen enriched gas |
US11364359B2 (en) | 2012-10-12 | 2022-06-21 | Inova Labs, Inc. | Method and systems for the delivery of oxygen enriched gas |
US9289717B2 (en) * | 2013-12-18 | 2016-03-22 | Carleton Life Support Systems Inc. | Air drying system for OBOGS |
US9440179B2 (en) | 2014-02-14 | 2016-09-13 | InovaLabs, LLC | Oxygen concentrator pump systems and methods |
US20170037604A1 (en) * | 2014-03-21 | 2017-02-09 | Siemens Aktiengesellschaft | Method for pressure control in a supply network, device and supply network |
US10443217B2 (en) * | 2014-03-21 | 2019-10-15 | Siemens Aktiengesellschaft | Method for pressure control in a supply network, device and supply network |
US10463816B2 (en) | 2014-08-28 | 2019-11-05 | Norton (Waterford) Limited | Compliance-assisting module for an inhaler |
US11660408B2 (en) | 2014-08-28 | 2023-05-30 | Norton (Waterford) Limited | Compliance-assisting module for an inhaler |
US20170281897A1 (en) * | 2014-09-19 | 2017-10-05 | Koninklijke Philips N.V. | Device for providing supplemental oxygen to a subject |
US20180207373A1 (en) * | 2015-06-03 | 2018-07-26 | Microdose Therapeutx, Inc. | Medical device notification system |
US10300224B2 (en) * | 2015-06-03 | 2019-05-28 | Microdose Therapeutx, Inc. | Medical device notification system |
US11364358B2 (en) * | 2015-06-30 | 2022-06-21 | Vapotherm, Inc. | Nasal cannula for continuous and simultaneous delivery of aerosolized medicament and high flow therapy |
US20170000965A1 (en) * | 2015-06-30 | 2017-01-05 | Vapotherm, Inc. | Nasal cannula for continuous and simultaneous delivery of aerosolized medicament and high flow therapy |
CN109069777A (en) * | 2016-01-21 | 2018-12-21 | 呼吸科技公司 | Modular ventilation system |
ES2629065A1 (en) * | 2016-02-05 | 2017-08-07 | Pedro PÉREZ OJEDA | Domestic device for ozonetherapy (Machine-translation by Google Translate, not legally binding) |
US20220161274A1 (en) * | 2016-02-08 | 2022-05-26 | Inova Labs, Inc. | System and method of desorbing nitrogen from particles |
US11247014B2 (en) * | 2016-02-24 | 2022-02-15 | Teijin Pharma Limited | Oxygen concentrator |
US11458274B2 (en) | 2016-05-03 | 2022-10-04 | Inova Labs, Inc. | Method and systems for the delivery of oxygen enriched gas |
US10792453B2 (en) * | 2016-05-24 | 2020-10-06 | Inogen, Inc. | Oxygen gas concentrator with outlet accumulator |
US20180001048A1 (en) * | 2016-05-24 | 2018-01-04 | Silverbow Development, Llc | Oxygen gas concentrator with outlet accumulator |
US20170340851A1 (en) * | 2016-05-24 | 2017-11-30 | Silverbow Development, Llc | Oxygen gas concentrator with outlet accumulator |
US11964105B2 (en) | 2016-05-24 | 2024-04-23 | Inogen, Inc. | Oxygen gas concentrator with outlet accumulator |
US11291789B2 (en) | 2016-06-30 | 2022-04-05 | Vapotherm, Inc. | Cannula device for high flow therapy |
US11446457B2 (en) | 2017-08-25 | 2022-09-20 | ResMed Pty Ltd | Methods and apparatus for treating a respiratory disorder |
WO2019036768A1 (en) * | 2017-08-25 | 2019-02-28 | ResMed Pty Ltd | Methods and apparatus for treating a respiratory disorder |
US11724056B2 (en) | 2017-09-08 | 2023-08-15 | Vapotherm, Inc. | Birfurcated cannula device |
US11185656B2 (en) * | 2018-12-05 | 2021-11-30 | Aires Medical LLC | Pulsed pressure swing adsorption system and method |
US11583650B2 (en) | 2019-06-28 | 2023-02-21 | Vapotherm, Inc. | Variable geometry cannula |
US11878115B2 (en) | 2019-09-26 | 2024-01-23 | Vapotherm, Inc. | Internal cannula mounted nebulizer |
US20210154427A1 (en) * | 2019-11-27 | 2021-05-27 | ResMed Asia Pte. Ltd. | Oxygen concentrator with improved sieve bed construction |
CN112755347A (en) * | 2020-12-31 | 2021-05-07 | 东莞永昇医疗科技有限公司 | Ventilator shutdown control method, ventilator and computer readable storage medium |
Also Published As
Publication number | Publication date |
---|---|
EP2906280A1 (en) | 2015-08-19 |
EP2906280B1 (en) | 2018-09-26 |
EP2906280A4 (en) | 2017-05-31 |
JP2020189120A (en) | 2020-11-26 |
NZ707260A (en) | 2017-12-22 |
EP3578220B1 (en) | 2023-05-24 |
EP3578220A1 (en) | 2019-12-11 |
AU2018203024A1 (en) | 2018-05-17 |
US9440180B2 (en) | 2016-09-13 |
EP4249104A3 (en) | 2023-10-04 |
WO2014059409A1 (en) | 2014-04-17 |
JP6745828B2 (en) | 2020-08-26 |
US20150335849A1 (en) | 2015-11-26 |
US9782557B2 (en) | 2017-10-10 |
AU2013328916A1 (en) | 2015-05-14 |
JP2018122112A (en) | 2018-08-09 |
JP7086146B2 (en) | 2022-06-17 |
JP2015531310A (en) | 2015-11-02 |
BR112015008209A2 (en) | 2017-07-04 |
IL238205A0 (en) | 2015-05-31 |
US20170087326A1 (en) | 2017-03-30 |
EP4249104A2 (en) | 2023-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9782557B2 (en) | Oxygen concentrator systems and methods | |
US11684744B2 (en) | Method and systems for the delivery of oxygen enriched gas | |
US9717876B2 (en) | Dual oxygen concentrator systems and methods | |
US9440179B2 (en) | Oxygen concentrator pump systems and methods | |
US20220161274A1 (en) | System and method of desorbing nitrogen from particles | |
US20190134340A1 (en) | Method and systems for the delivery of oxygen enriched gas | |
US20180369532A1 (en) | Water removal system for an oxygen concentrator system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: INOVA LABS, INC, A DELAWARE COMPANY, TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WILKINSON, WILLIAM R.;NEBRIGIC, DRAGAN;REEL/FRAME:032120/0466 Effective date: 20131216 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |